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315Genetic disorders and disease mechanisms
Mutations in SERPINB8 underlie a mild peeling skin phenotype
M Pigors,1 L Heinz,2 V Plagnol,3 J Fischer,2 M Kharfi,4 GG Lestringant,5 D Kelsell1 and 
DC Blaydon1 1 Blizard Institute, Centre for Cutaneous Research, Barts and The London 
School of Medicine and Dentistry, Queen Mary University of London, London, United 
Kingdom, 2 Institute of Human Genetics, University Medical Center Freiburg, Freiburg, 
Germany, 3 Genetics Institute, University College London, London, United Kingdom, 4 
Department of Dermatology, Charles Nicolle Hospital, Tunis, Tunisia and 5 British Ministry 
of Defence, London, United Kingdom
Several genes have been implicated in the pathogenesis of peeling skin diseases, including those 
encoding proteins involved in cornified envelope formation (TGM5), corneocyte adhesion (CDSN), 
or protease inhibition (CSTA, CAST). Here, we report two families with putative loss-of-function 
mutations in the serpin peptidase inhibitor, clade B, member 8, SERPINB8, in association with a 
mild peeling skin phenotype. Whole exome sequencing of two affected sibs from a consanguineous 
Tunisian family, revealed a homozygous frameshift mutation, c.946delA; p.K316Sfs*90, predicted to 
lead to loss of the reactive site loop of SERPINB8, which is crucial for forming the SERPINB8-protease 
complex. Using Sanger sequencing, a homozygous missense mutation, c.T2C; p.M1T, predicted 
to result in an N-terminal truncated protein, was identified in a second family from the United 
Arab Emirates. In vitro studies utilizing siRNA-mediated knockdown of SERPINB8 in keratinocytes 
showed that in the absence of the protein, there is a cell-cell adhesion defect, particularly when 
cells are subjected to mechanical stress. Immunoblotting and immunostaining demonstrated an 
upregulation of desmosomal proteins and altered expression of tight junction markers. Furthermore, 
immunoblotting of cell lysates collected from concentrated keratinocyte medium indicated that 
SERPINB8 is secreted from keratinocytes in vitro and forms a complex with a yet unknown target 
protease. In conclusion, we describe a novel causative gene that is associated with a mild peeling 
skin phenotype and we provide evidence that SERPINB8 contributes to the mechanical stability of 
intercellular adhesions in the upper epidermal layers.    
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Klk5 knock-out reverses cutaneous hallmarks of Netherton syndrome
L Furio,1 G Pampalakis,2 I Michael,3 A Nagy,3 G Sotiropoulou2 and A Hovnanian1 1 INSERM 
UMR 1163, Laboratory of Genetic Skin Diseases, Imagine Institute, University Paris Descartes 
- Sorbonne Paris Cité,, Paris, France, 2 Department of Pharmacy, School of Health Sciences, 
University of Patras,, Rion-Patras, Greece and 3 Samuel Lunenfeld Research Institute, Mount 
Sinai Hospital,, Toronto, ON, Canada
Netherton Syndrome (NS) is a rare and severe autosomal recessive skin disease which can be 
life-threatening in infants, characterized by extensive skin desquamation, inflammation, allergic 
manifestations and a specific hair shaft defect. NS is caused by loss-of-function mutations in SPINK5 
encoding the LEKTI serine protease inhibitor. LEKTI deficiency results in unopposed activities of 
several kallikrein-related peptidases (KLKs) and aberrantly increased proteolysis in the epidermis. 
Lekti-deficient mice (Spink5-/-) recapitulate the NS phenotype, display enhanced epidermal Klk5 
and Klk7 protease activities and die within a few hours after birth from dehydration resulting from 
a severe skin barrier defect. In this study, we developed a new murine model in which Klk5 and 
Spink5 were both knocked out to assess whether Klk5 deletion is sufficient to reverse the NS phe-
notype in Spink5-/- mice. We show that Klk5 knock-out in Lekti-deficient newborn mice rescues 
neonatal lethality, reverses the skin barrier defect, restores epidermal structure and prevents skin 
inflammation. Specifically, Klk5 inactivation reduced epidermal proteolytic activity, in particular 
its downstream targets proteases KLK7, KLK14 and ELA2. Desmosomes and corneodesmosomes 
remained intact, epidermal differentiation was restored, skin inflammation and allergy did not 
develop, Il-1b, Il17A and Tslp expression was significantly reduced. Our results provide in vivo 
evidence that Klk5 knock-out is sufficient to reverse NS-like symptoms manifested in Spink5-/- skin. 
These findings illustrate the crucial role of protease regulation in skin homeostasis and inflammation, 
and establish KLK5 inhibition as a major therapeutic target for NS.    
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Postzygotic activating mutations of MTOR cause hypomelanosis of Ito with brain overgrowth
P Vabres,1 VE Parker,2 J St-Onge,3 Y Duffourd,3 RG Knox,2 RK Semple,2 L Faivre3 and 
J Riviere3 1 Dermatology, Centre Hospitalier Universitaire, Dijon, France, 2 The University 
of Cambridge Metabolic Research Laboratories, Institute of Metabolic Science, Cambridge, 
United Kingdom and 3 GAD Research Group, Université de Bourgogne Franche-Comté, 
Dijon, France
The genetic basis of hypomelanosis of Ito (HMI) has remained elusive. HMI is an umbrella term for 
conditions with hypopigmentation along Blaschko’s lines associated with systemic features, mainly 
cerebral involvement and epilepsy, suggesting underlying somatic mosaicism. Indeed, mosaic chro-
mosome anomalies have been reported, but do not account for a majority of HMI patients. We 
ascertained five unrelated HMI patients with brain overgrowth and variable intellectual disability 
and epilepsy. Using whole-exome and targeted deep sequencing on their skin and blood DNA, 
we identified in all five subjects mosaic activating missense mutations in MTOR, which encodes 
the mechanistic target of rapamycin (mTOR), a core component of the PI3K-AKT-mTOR pathway. 
Mutations were mainly present in the skin with variable levels of mosaicism, and almost undetect-
able in the blood. In the most severely affected individual, who had severe cognitive impairment 
and intractable seizures, hyperactivation of mTOR signaling was found on her cultured dermal 
fibroblasts, with increased phosphorylation of AKT and p70 ribosomal protein S6 kinase under 
amino acid deprivation. Since the p.Glu2419Lys variant she carried was known to be sensitive 
to rapamycin in vitro and in vivo, we initiated everolimus therapy, which unfortunately failed to 
improve seizure and was withdrawn after five months. However, mTOR inhibitors remain candidate 
drugs for neurological involvement in this subtype of HMI. Delineation of a clinical and molecular 
subgroup of HMI caused by mosaic activating MTOR mutations underlines the value of careful 
phenotyping and next generation sequencing in HMI, and may pave the way for new treatments 
with mTOR inhibitiors. Our results also provide additional evidence for involvement of the PI3K – 
mTOR pathway in pigmentation disorders.    
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Post-zygotic mutations in GNA11 and GNAQ cause phakomatosis pigmentovascularis
A Thomas,1 Z Zeng,2 J Riviere,3 R O’Shaughnessy,1 L Al-Olabi,1 J St-Onge,3 P Vabres,3 
E Patton2 and VA Kinsler1 1 UCL Institute of Child Health, London, United Kingdom, 2 MRC 
Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom and 3 Dijon 
University Hospital, Dijon, France
Phakomatosis Pigmentovascularis (PPV) is a group of rare congenital disorders defined by the 
co-occurrence of specific pigmentary and vascular birthmarks, with associated neuro-vascular, 
ophthalmological, overgrowth and malignant complications. To identify the genetic basis of this 
condition DNA was extracted from skin biopsies of both cutaneous lesions and from blood, and 
sequenced for mosaic mutations in candidate genes using selective amplification of mutant alleles 
and targeted next generation sequencing. Missense mutations in the GTP binding site of Galpha 
subunit GNA11 were found in 4/8 patients (p.R183C (n=3), p.R183S (n=1)), and in GNAQ in 
2/8 (p.R183C), with 2/8 wild-type. The same mutation was found in both birthmarks in any one 
individual, but was absent in blood, consistent with a single post-zygotic mutation to a pluripotent 
precursor cell. Transgenic mosaic zebrafish models expressing mutant GNA11R183C under promoter 
mitfa developed extensive patches of cutaneous melanocytosis, recapitulating the human pheno-
type. In vitro expression of mutant GNA11R183C in human HEK293 cells demonstrated activation 
of the downstream p38 MAPK signalling pathway. Our work unequivocally demonstrates that 
PPV is caused by a mosaic activating somatic GNA11 or GNAQ mutation during embryogenesis.   
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Nanogel coupled cutaneous enzyme delivery as protein replacement therapy for autosomal 
recessive congenital ichthyosis (ARCI)
R Plank,1 R Casper,2 K Obst,3 M Hermann,4 M Calderón,5 S Hedtrich,3 KM Eckl1 and 
H Hennies1 1 Center for Dermatogenetics, Div. of Human Genetics, Innsbruck, Austria, 
2 Cologne Center for Genomics, Univ. of Cologne, Cologne, Germany, 3 Institute of 
Pharmaceutical Sciences, Freie Universität Berlin, Berlin, Germany, 4 Dept. of Anaestesiology, 
Innsbruck Medical University, Innsbruck, Austria and 5 Inst. for Chemistry and Biochemistry, 
Freie Universität Berlin, Berlin, Germany
Autosomal recessive congenital ichthyosis (ARCI) is a rare cornification disorder with impaired 
skin barrier function and no causative treatment to date. In this study we aim for a novel, person-
alized therapy for ARCI through substituting the respective proteins TGase1, 12R-LOX and eLOX3. 
For production of TGase1 we have used mammalian protein expression in HEK 293 cells. The 
enzyme was checked by FACS and Western Blot analysis and TGase1 activity was confirmed. 
For efficient delivery of the protein into keratinocytes we coupled TGase1 to thermoresponsive 
PNIPAM-dPG nanogel (NG) and carried out protein substitution experiments on cultured normal 
and TGM1-knockdown (TGM1-KD) 2D keratinocytes as well as on 3D full thickness ARCI skin 
models. 2D and 3D experiments showed that TGase1 was successfully delivered into keratinocytes. 
On analysis of delivered TGase1 over time, nearly all extrinsic protein was gone 24h after enzyme 
delivery in 2D experiments. Therefore we defined a treatment schedule for skin models with repeated 
applications of NG/TGase1. We could show that TGase1 was actually present in TGM1–KD mod-
els after treatment and importantly, permeability assays inticated that the barrier function of NG/
TGase1 treated TGM1-KD models was restored. ARCI skin models are further characterized for 
TGase1 activity, viability and ceramide profiles. Our findings revealed an advanced topical drug 
delivery system suitable for cutaneous protein replacement as a promising approach to personalized 
therapy for ARCI. After further experiments with patient cells, optimization of epidermal delivery 
and toxicity tests we will adapt our system also to other proteins involved in congenital ichthyosis.   
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Familial aplasia cutis congenita is caused by a defect in ribosome biogenesis
AG Marneros Dermatology, Massachusetts General Hospital/Harvard Medical School, 
Charlestown, MA
Genodermatoses that manifest with a wound at birth provide the opportunity to identify novel genes 
that are important for skin morphogenesis. Aplasia cutis congenita (ACC) is a genodermatosis that 
presents with a scalp skin defect at birth. We have identified several families with autosomal domi-
nant ACC. We have combined genome-wide linkage analysis with exome sequencing approaches 
to identify the genetic basis for ACC. A mutation in the ribosomal biogenesis GTPase BMS1 was 
identified in autosomal dominant ACC. This mutation results in a loss-of-function BMS1 allele 
and leads to a defect in pre-rRNA maturation of the small ribosomal subunit and subsequently 
a nucleolar stress response. The ribosomal dysfunction causes p21 activation and a G1/S phase 
arrest that leads to a reduced cell proliferation rate. Global proteomic and transcriptomic analyses 
confirmed a central role of p21 for the ACC phenotype. We speculate that elevated p21 levels due 
to a ribosome biogenesis defect impair both cell proliferation and differentiation of keratinocytes 
during embryonic development. This work identifies ACC as a novel ribosomopathy and provides 
a previously not appreciated link between ribosome biogenesis and skin morphogenesis. Additional 
work demonstrated genetic heterogeneity in ACC, raising the possibility to identify further ACC 
genes. Notably, other syndromes that manifest with aplasia cutis and other ectodermal defects harbor 
mutations in distinct genes that share common downstream pathways. We recently identified the 
gene for Scalp-Ear-Nipple syndrome, KCTD1, which is a transcriptional repressor of AP-2 and may 
through this mechanism affect p21 activation, similarly as observed in ACC. Thus, we hypothesize 
a common pathomechanism that results in the skin defects in ACC and Scalp-Ear-Nipple syndrome.   
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Inducible expression of gasdermin A3 in the epidermis causes skin inflammation and hair 
cycle defect
H Lin, P Lin and L Yang Institute of Celluar and System Medicine, National Health Research 
Institutes, Miaoli County, Taiwan
The epidermis provides a critical barrier, which is maintained by the epidermal keratinocytes under-
going constant turnover. Gene mutations which disrupt keratincoyte proliferation, differentiation, 
and death are responsible for skin diseases. Gasdermin A (GSDMA) is expressed in epithelial cells 
of the upper gastrointestinal tract, lung, and skin; it is involved in apoptosis of the gastric epithelium 
cells and has been linked with asthma susceptibility in genetic association studies. The function of 
GSDMA in the skin remains unclear and could only be deduced from autosomal dominant mutations 
in gasdermin A3 (Gsdma3), an ortholog of GSDMA in mice, which caused progressive epidermal 
hyperplasia and alopecia. To test the hypothesis that autosomal dominance of Gsdma3 mutations 
are resulted from Gsdma3 gain-of-function, we generated a doxycycline-inducible double transgenic 
(DTg) mouse model to express GSDMA3 in the basal keratinocytes using KRT14-rtTA mouse line. We 
found that induced expression of Gsdma3 caused epidermal hyperplasia, inflammatory infiltrations, 
and hair cycle defect after depilation, which were associated with increased expression of TNF-α 
and IL-1α in the epidermis. These skin phenotypes are similar to those reported in Gsdma3 mutant 
mice. Moreover, necrotic keratinocytes and increased TUNEL-positive staining were found in the 
DTg epidermis. In primary keratinocytes isolated from the DTg epidermis, induced expression of 
Gsdma3 caused spontaneous necrosis and leakage of intracellular components with no evidence of 
autophagy, apoptosis, and endoplasmic reticulum stress. Our data suggest that the dominant muta-
tions in Gsdma3 are gain-of-function mutations, and that an innate immune-mediated mechanism 
underlies the skin inflammation phenotype of Gsdma3 mutant strains.    
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Multi-ethnic genome-wide association study of 21,000 cases and 95,000 controls identifies 
11 novel risk loci for atopic dermatitis
L Paternoster,2 M Standl,3 H Baurecht,1 DM Evans4 and S Weidinger1 1 Department of 
Dermatology, Venereology and Allergy, University Hospital Schleswig-Holstein, Kiel, 
Germany, 2 MRC Integrative Epidemiology Unit, University of Bristol, Bristol, United 
Kingdom, 3 Institute of Epidemiology I, Helmholtz Zentrum München - German Research 
Center for Environmental Health, Neuherberg, Germany and 4 University of Queensland 
Diamantina Institute, Translational Research Institute, University of Queensland, Brisbane, 
QLD, Australia
Atopic dermatitis (AD) is a highly heritable common chronic inflammatory skin disease. Previous 
genome-wide association studies (GWAS) have identified 21 genetic loci associated with AD in 
relatively small sample sizes compared to many other common complex diseases. We conducted 
the world’s largest GWAS of AD in 53,458 cases and 324,092 controls from 44 studies. In addition 
to carrying out a fixed effects meta-analysis in Europeans, we conducted a trans-ethnic meta-anal-
ysis including Japanese, African- and Latin-Americans. We identified 11 novel loci associated with 
AD at genome-wide levels of significance. One particularly interesting association involved SNPs 
near CD207, a gene selectively expressed in dendritic cells of the epidermis (Langerhans cells), 
putatively involved in antigen uptake and processing. These SNPs also showed strong association 
with CD207 expression in skin tissue from the MuTHER study (p=1x10-10). Thus, our results suggest 
a possible role for genetic factors influencing epithelial dendritic cell function in the aetiology of 
AD. In addition we also identified four secondary signals at known loci. Our results also showed a 
substantial genetic overlap between AD and other immune-mediated diseases, particularly inflam-
matory bowel disease (IBD). 39 of 163 SNPs robustly associated with IBD in a recent GWAS were 
at least nominally associated (p<0.05) with AD in our sample (35 of these in the same direction). 
Our results bring the total number of known AD risk loci to 32. All new loci include candidate genes 
with roles in regulating environmental sensing and adaptive immune responses, underscoring the 
important contribution of immune components to AD pathogenesis.    
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In vivo restoration of type VII collagen expression in human-skin-graft mouse model upon 
antisense oligonucleotide-mediated exon skipping
J Bremer,1 PC van den Akker,2 A Gostynski,1 MF Jonkman,1 A Aartsma-Rus3 and AM Pasmooij1 
1 Dermatology, University of Groningen, University Medical Center Groningen, Groningen, 
Netherlands, 2 Genetics, University of Groningen, University Medical Center Groningen, 
Groningen, Netherlands and 3 Human Genetics, University Medical Center Leiden, Leiden, 
Netherlands
Recessive dystrophic epidermolysis bullosa generalized severe (RDEB-gen sev) is caused by reces-
sive null mutations in COL7A1, the gene for type VII collagen (Col7). The absence of Col7 leads to 
blistering of the epithelium upon trivial trauma. Because most exons of COL7A1 are in-frame and the 
triple-helical domain has a repetitive amino acid sequence, this gene seems a perfect candidate for 
antisense oligonucleotide (AON)-mediated exon skipping. We examined the feasibility of AON-me-
diated exon skipping as therapeutic approach for RDEB-gen sev. To examine AON-mediated exon 
skipping, primary cultured fibroblasts and keratinocytes were transfected with specific AONs and 
a skin graft mouse model was used to examine the capability to induce systemic exon skipping. 
RT-PCR showed exon skipping of the target exon on the RNA level in vitro upon transfection. 
This exon skipping lead to the restoration of Col7 expression in 30-50% of patient’s fibroblasts 
and keratinocytes, respectively. To examine our AONs in vivo, a human skin graft mouse model 
was validated. With this model well-differentiated skin was reconstituted out of primary cultured 
fibroblasts and keratinocytes on the back of athymic nude mice. Six mice were successfully grafted 
with patient fibroblasts and keratinocytes. Four were treated with AONs and two received saline 
solution as control. The injections were subcutaneously administered at 7 cm distance of the graft. 
After the treatment phase, the skin grafts were harvested, cryosections were cut and analysed for 
exon skipping at the RNA level and stained for Col7 expression. RT-PCR revealed exon skipping 
in the treated patient grafts. Moreover, restoration of Col7 expression was observed in the patient 
skin grafts treated with AONs. These results advocate AON-mediated exon skipping as therapeutic 
approach for RDEB-gen sev.    
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IL-17C, TNFα and IL-36 compensate for loss of IL-6 and identify novel signals facilitating the 
transition between uninvolved and involved psoriasis skin
P Klenotic,1 Y Fritz,1 A Johnston,2 TS McCormick1 and NL Ward1 1 Derm, Case Western 
Reserve University, Cleveland, OH and 2 Derm, University of Michigan, Ann Arbor, MI
IL-17C is proinflammatory and highly expressed in lesional psoriasis skin. Mice engineered to 
overexpress IL-17C in KCs (K5-IL-17C) develop a skin disease phenocopying human psoriasis, 
including well-demarcated uninvolved (PN) and involved (PP) skin. PN skin from K5-IL-17C mice 
has increased IL-6 and TNFα protein (~2.5-fold; P<0.05) vs. controls and these increase ~10-fold 
in PP skin (P<0.05) suggesting a role for these molecules in the PN-PP transition. We hypothesize 
that IL-6-TNFα-IL-17C synergy contributes to the PN-PP transition and disease severity. K5-IL-17C 
and IL-6KO mice were mated and skin inflammation examined. Less severe skin inflammation 
developed in K5-IL-17C-IL-6KO mice vs. K5-IL-17C mice between 10-12 wks of age evidenced by 
less body surface area involvement (P<0.05; n=8/grp); this difference was eliminated by 14 wks of 
age suggesting that cellular and molecular events within the skin compensate for IL-6 absence and 
promote the PN-PP transition. PN skin of 10 and 14 wk old K5-IL-17C-IL-6KO and K5-IL-17C mice 
was compared and decreases in acanthosis, angiogenesis, skin CD4+, CD8+ and F4/80+ cells were 
seen at 10 wks (all P<0.04) and were abrogated by 14 wks. Serum TNFα and cutaneous IL-17C, 
IL-36β and IL-36γ were also reduced (~2-5-fold; P<0.05) at 10 wks yet increased significantly at 14 
wks, as did skin-TNFα (3-fold; P=0.003) perhaps compensating for the lack of IL-6. To examine the 
importance of IL-6, primary human KCs were stimulated with IL-6 and significant increases in TNFα, 
IL-17C, IL-36β and IL-36γ (n=6; P<0.05) were observed and increased further when co-stimulated 
with IL-17C±TNFα. Finally, PN skin of K5-IL-17C-IL-6KO mice reconstituted with intradermal IL-6 
every other day between 8-10 wks of age had their skin phenotype return to levels similar to K5-IL-
17C mice. These data demonstrate the ability of IL-17C, TNFα and IL-36 to compensate for loss of 
IL-6 and identify novel signals facilitating the PN-PP transition in psoriasis skin.    
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New plectinopathy affecting only skin from plectin isoform 1a deficiency
MF Jonkman,1 K Gostynska,1 H Pas,1 AM Pasmooij,1 MJ Castañón2 and G Wiche2 1 
Dermatology, University Medical Centre Groningen, Groningen, Netherlands and 2 
Biochemistry and Cell Biology, University of Vienna, Vienna, Austria
PLEC, the gene encoding the cytolinker protein plectin, has eight tissue specific isoforms in humans, 
arising by alternate splicing of the first exon. To date, all PLEC mutations that cause epidermolysis 
bullosa simplex (EBS) were found in exons common to all isoforms. Due to the ubiquitous presence 
of plectin in mammalian tissues, EBS from recessive plectin mutations is always associated with 
extracutaneous involvement including muscular dystrophy, pyloric atresia and cardiomyopathy. We 
studied a consanguineous family with sisters having isolated blistering suggesting EBS. Skin disease 
started with foot blisters at walking age and became generalized at puberty while sparing mucous 
membranes. We found hypoplastic hemidesmosomes and intra-epidermal ‘pseudojunctional’ cleav-
age fitting EBS. Screening for cardiomyopathy and muscle dystrophy showed no abnormalities. DNA 
sequencing revealed a homozygous nonsense mutation (c.46C>T; p.Arg16X) in the first exon of 
the plectin variant encoding plectin isoform 1a (P1a), the isoform predominantly expressed at the 
dermal-epidermal junction of normal human epidermis. The patients showed absent P1a expression 
in the epidermis by immunofluorescence antigen mapping, and western blotting showed ~84% 
reduction of pan-plectin in patient keratinocyte extracts. Also the transcript levels of P1a were 
significantly reduced as witnessed by qRT-PCR. P1a was not expressed in control myocardium 
and striated muscle. Here, we report the first cases of autosomal-recessive EBS from P1a deficiency 
affecting skin, while mucous membranes, heart and muscle were spared. P1a is the dominant isoform 
in the epidermal basal cells. Our study characterizes yet another of the eight isoforms of plectin, 
and add a tissue specific phenotype to the spectrum of ‘plectinopathies’ produced by mutations of 
unique first exons of this gene.    
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iRHOM2 regulation of ADAM17 is a key regulator of epithelial growth factor signalling 
MA Brooke, B Fell and D Kelsell Blizard Institute, Barts & The London School of Medicine & 
Dentistry, London, United Kingdom
We have previously linked point mutations in the rhomboid iRHOM2 to Tylosis with oesophageal 
cancer (TOC), a dominantly-inherited disease of palmoplantar keratoderma, and the only known 
inherited oesophageal cancer susceptibility syndrome. In keratinocyte cell lines, these iRHOM2 
mutations result in dysregulation of the broad spectrum ectodomain sheddase ADAM17, an enzyme 
whose maturation and activity iRHOM2 regulates. TOC-associated iRHOM2 mutations result in 
increased ADAM17 maturation and translocation to the keratinocyte plasma membrane, relative to 
controls, and highly upregulated constitutive shedding of ADAM17 substrates, including the EGFR 
ligands amphiregulin, TGFα and HB-EGF. This is accompanied by constitutive hyperactivation of 
EGFR & ERK signalling in TOC keratinocytes, and a phenotype of significantly increased proliferation 
and migration, with the increased growth factor shedding and proliferative phenotype sensitive 
to ADAM17 or EGFR inhibition. This upregulated EGFR ligand shedding also results in increased 
transglutaminase 1 activity in the epidermis of TOC-affected skin and in 3D TOC keratinocyte cul-
tures, relative to controls. Additionally, TOC keratinocytes display strong constitutive upregulation 
of IL-6 and IL-8 expression and secretion, which is sensitive to inhibition of ADAM17 or the EGFR; 
suggesting that the iRHOM2-ADAM17-EGFR axis drives pro-inflammatory cytokine secretion in 
keratinocytes. As well as IL-6, shedding of the (ADAM17 substrate) IL-6 receptor is also significantly 
upregulated. Together with IL-6, this drives a constitutive upregulation of STAT3 signalling in TOC 
keratinocytes. Furthermore, the significant upregulation of pro-inflammatory cytokines suggests 
upregulation of NFκB signalling in TOC keratinocytes, borne out by the presence of increased con-
stitutive IκBα phosphorylation. These findings reveal the key role of iRHOM2 in growth factor regu-
lation in the skin. This, and the association of iRHOM2 mutations with oesophageal cancer, offers 
new insights into mechanisms of epidermal hyperproliferation and oesophageal carcinogenesis.   
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A Hay-Wells syndrome mouse model reveals a crucial function for p63 in regulating skin 
mechanical integrity and thymic stromal lymphopoietin levels
M Mollo,1 L Cirillo,1 JL Johnson,2 E Polishchuk,3 R Polishchuk,3 D Antonini4 and C Missero1 
1 CENIGE-Center for Genetic Engineering, Naples, Italy, 2 Pathology and Dermatology, 
Feinberg School of Medicine, Chicago, IL, 3 Telethon Institute of Genetics and Medicine 
(TIGEM), Naples, Italy and 4 IRCCS SDN, Naples, Italy
Hay-Wells or Ankyloblepharon- Ectodermal defects Cleft lip/palate (AEC) syndrome is a severe 
genetic disorder characterized by congenital erythroderma and long-lasting skin erosions. To identify 
molecular mechanisms underlying the severe skin defects, we generated a conditional knock-in 
mouse carrying an inducible p63 mutation to model the human disorder. In AEC mice, focal skin 
erosions and scaling were accompanied by reduced mechanical stress resilience caused by a 
selective decrease in keratin expression, and progressive skin inflammation due to strongly elevated 
Thymic stromal lymphopoietin (Tslp) protein. Epidermal-derived Tslp was circulating in the blood, 
causing a dramatic expansion of immature B-cells in the bone marrow and spleen. Genetic ablation 
of Tslp in the epidermis significantly reduced skin inflammation, rescued B-cell differentiation, and 
increased survival in AEC mice. In AEC mouse epidermis, Tslp induction was due to impairment 
of Notch signaling caused by reduced expression of the p63 direct target genes Notch1 and Jag2. 
Reactivating Notch signaling suppressed Tslp expression in AEC mouse keratinocytes. Interestingly, 
extensive skin erosions in human AEC syndrome were accompanied by a similar impairment of 
Notch1 expression and increased Tslp, which could be causative of B-lymphoproliferative disorder. 
Our studies indicate that extensive skin erosions in AEC syndrome cause excessive Tslp production, 
leading to inflammation and an autoimmune lymphoproliferative disorder.    
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The International Psoriasis Council Exome Chip Project: Exome arrays reveal known and 
novel coding variant associations
International Psoriasis Council Exome Chip Consortium1,2,3 1 King’s College London, London, 
UK, 2 Christian-Albrechts-University, Kiel, Germany, 3 University of Michigan Ann Arbor, 
Michigan, USA
Genetic association studies, including genome-wide association studies and the recent international 
immunochip collaboration, have identified more than 50 common loci associated with psoriasis 
susceptibility in European populations. However, a substantial fraction of the genetic contribution 
to psoriasis risk remains undefined. Direct investigation of functional genetic variation has the 
potential to further elucidate the molecular genetic contributants to the heritability of psoriasis. 
Focus on protein-altering variation, and particularly low-frequency and rare coding variants, will 
inform the fine mapping of established common susceptibility loci and has the potential to identify 
low-frequency and rare susceptibility alleles overlooked by previous studies of common variation. 
We examined the role of functional protein coding variation in psoriasis susceptibility in a large 
case-control study incorporating 11,456 cases and 21,355 controls. Genotyping was performed 
at three centres (Michigan, USA; Kiel, Germany; and London, UK) using Illumina and Affymetrix 
Exome arrays that are designed to interrogate variants predicted to alter protein sequence. The 
two platforms share 231,130 variants including 28,181 common (minor allele frequency 5-50%), 
21,578 low-frequency (0.5-5%) and 184,371 rare (< 0.5%) variants. We undertook a standard error 
weighted meta-analysis of 72,260 SNPs, outside of the MHC region, which are polymorphic in 
each of the three datasets. We observed genome-wide association (p < 5×10-8) of common missense 
alleles within established psoriasis susceptibility loci, including those in IL13, STAT2, TRAF3IP2, 
TYK2, and ERAP1. Aggregation tests for low-frequency and rare variation also revealed exome-wide 
association (p < 2.5×10-6) for several genes, including IFIH1. These observations provide a basis for 
a more detailed analysis to determine the functional alleles responsible for these association signals.   
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Antisense Oligonucleotide therapy for the correction of COL17A1 splicing in junctional 
epidermolysis bullosa
N Friedl, T Lettner, J Bauer and V Wally Department of Dermatology Paracelsus Mediacal 
University, EB House Austria, Salzburg, Austria
A splice mutation in COL17A1 (380-1 G to A) in the intron 6/exon 7 boundary leads to the deletion 
of 16 nucleotides of exon 7 and the phenotype of junctional epidermolysis bullosa (JEB). Antisense 
oligonucleotides (AON) have been shown to be applicable for the restoration of the splice pattern 
in duchenne’s muscle dystrophy and we here show the feasibility of the method to restore the 
wildtpye splice pattern in a junctional EB minigene approach. In order to block the cryptic acceptor 
site created by the point mutation and to induce the utilization of an downstream in-frame acceptor 
site, we designed two different antisense oligonucleotides, which both lead to either the skipping 
of exon 7, resulting in a slightly shortened version of the collagen XVII protein, or the restoration 
of the original splice pattern and a normal collagen XVII expression. We transduced both antisense 
oligonucleotides into HEK293 cells expressing a minigene, comprising the mutated gene portion 
or the wildtype gene portion, respectively. The integration of a 3’ His-/FLAG-Tag facilitates the 
discrimination between the abberantly spliced and the wildtype transcript. We showed, that the 
transduction of both AONs leads to a partial restoration of the wildtype splice pattern on mRNA 
level. Upon verification of the results on protein level, these AONs can be used in an endogenous 
setting, providing important information on the applicability of this method for the treatment of EB.   
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Decreased expression of activin A receptor 1C may result in Ca2+-induced aberrant skin 
hypersensitivity. 
E Kim, D Lee, Y Kim, H Eun and J Chung Department of Dermatology, Seoul National 
University College of Medicine, Laboratory of Cutaneous Aging Research, Center for Medical 
Innovation, Seoul National University Hospital, Institute of Human-Environment Interface 
Biology, Seoul National University, Seoul, Korea (the Republic of)
Sensitive skin is a hyperactive skin condition characterized by exaggerated sensory symptoms in 
response to internal stimulants and external irritants. Here we discovered that activin A receptor 
1C (ACVR1C), a type I serine/threonine kinase receptor for the TGF-β family, is a critical regulator 
in the development of sensitive skin. ACVR1C expression was markedly decreased in sensitive skin 
compared with non-sensitive skin. Abnormal Ca2+ influx may cause excessive pain through TRPV1 in 
vivo, and Fluo-4-AM staining revealed that ACVR1C-knockdown cells exhibited markedly enhanced 
responses in intracellular Ca2+ concentration following calcium ionophore A23187 treatment. Fur-
thermore, knockdown of ACVR1C induced the expression of nociceptors such as TRPV1, ASIC3 and 
CGRP, which are responsible for abnormal pain elicitation in sensitive skin. Intriguingly, treatment 
of RD cells with Nodal, an ACVR1C ligand, led to a substantial reduction in the expression of 
TRPV1 and CGRP as well as the Ca2+ influx which was increased by knockdown of ACVR1C. Taken 
together, our findings demonstrate that ACVR1C play crucial roles in the pathogenesis of sensitive 
skin, and the activation of ACVR1C in vitro successfully reversed nociceptor activation in RD cells, 
thereby suggesting a novel therapeutic approach for aberrant pain associated with sensitive skin.   
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Insulin and Insulin-like growth factor-1 Can Modulate the Phosphoinositide-3-kinase / Akt/ 
FoxO1 Pathway in SZ95 Sebocytes
Y Mirdamadi,1 A Thielitz,1 CC Zouboulis,2 U Bommhardt,3 S Quist1 and H Gollnick1 1 
Department of Dermatology and Venereology, Otto-von-Guericke-University, Magdeburg, 
Germany, 2 Departments of Dermatology, Venereology, Allergology and Immunology, 
Dessau Medical Center, Dessau, Germany and 3 Institute of Molecular and Clinical 
Immunology, Otto-von-Guericke-University, Magdeburg, Germany
A recent hypothesis suggests that a high glycaemic load diet-associated increase of insulin-like 
growth factor-1 (IGF-1) and insulin may promote acne by reducing nuclear localization of the 
forkhead box-O1 (FoxO1) transcription factor via activation of the phosphoinositide-3-kinase (PI3K)/ 
Akt pathway. Innate immunity molecules like toll-like receptor2 and 4 (TLR2/4) are expressed in 
sebocytes and the cytosolic domains of TLRs contain a PI3K binding motif and there is an interaction 
between PI3K and TLRs. Using SZ95 sebocytes as a model, we investigated the yet hypothetical 
nutrigenomic regulation of insulinotropic dietary factors on acne. SZ95 sebocytes were treated 
with different concentrations of IGF-1 and insulin +/- PI3K inhibitor in a time-dependent manner. 
Cytoplasmic and nuclear protein expression of p-Akt and p-FoxO1 and FoxO transcriptional activity 
was analysed. The proliferation and differentiation of sebocytes and their TLR2/4 expression were 
determined. We found that high concentrations of IGF-1 and insulin differentially stimulate the PI3K/ 
Akt/ FoxO1 pathway by an early up-regulation of cytoplasmic p-Akt and delayed up-regulation of 
p-FoxO1 resulting in FoxO1 shift to the cytoplasm and the reduction of FoxO transcriptional activ-
ity. 0.1 and 1 μM IGF-1 reduced sebocytes proliferation but increased differentiation to a greater 
extent than insulin (0.1 and 1 μM). TLR2/4 expression was up-regulated upon 0.1 and 1 μM IGF-1 
and insulin-induced activation of the PI3K pathway and providing another important link between 
dietary factors and inflammation in acne beyond microbial involvement. These data provide the first 
in vitro evidence that FoxO1 might be involved in the regulation of growth-factor-stimulatory effects 
on sebaceous lipogenesis and inflammation in the pathological condition of acne.    
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Topical Carrier for the Delivery of Therapeutic RNAi Molecules to Human (Impaired) Skin
E Desmet, M Van Gele and J Lambert Dermatology, Ghent University, Ghent, Belgium
In this study is was our goal to optimize our in-house characterized ultradeformable SECosomes 
which have been proven to enable siRNA delivery in cultured primary skin cells and in the viable 
epidermis of ex vivo human skin after topical application. However, skin penetration efficiency 
and cellular internalization of the siRNA remained debatable. By altering their composition, we 
aimed to improve their use as topical delivery system for therapeutic RNAi molecules in the treat-
ment of skin diseases. The ‘SEC’ were adapted by changing: the amount/type of helper lipid, the 
surfactant used and/or EtOH percentage, yielding 6 additional formulations. These were analyzed 
for their potential as RNAi delivery vesicle by examining their size, surface charge, morphology, 
encapsulation efficiency and in vitro transfection efficacy in melanocytes and in (psoriasis-induced) 
keratinocytes. The formulation with the best characteristics was subjected to ex vivo penetration 
studies in excised (psoriatic) human skin and in Franz diffusion cells. In addition, the therapeutic 
efficacy was evaluated in MatTek’s in vitro psoriasis tissue model. The ‘DDC642’ formulation, 
containing 2 helper lipids, produced the most favorable vesicles as indicated by their size, homo-
geneity, morphology, encapsulation efficiency (≥ 89%) and in vitro transfection efficacy of RNAi 
molecules in primary human skin cells. In addition, they showed a nice penetration through the 
different epidermal layers of normal human skin, without transdermal delivery, whereas the SEC 
remained restricted to the stratum corneum. In psoriatic skin, both SEC and DDC642 penetrated the 
epidermis and rete ridges as the skin barrier is disrupted. Treatment of a psoriasis tissue model with 
DEFB4 siRNA-containing DDC642 lipoplexes showed a significant decrease in human β-defensin 
2 protein expression, providing a proof of concept. We identified a promising topical carrier, called 
‘DDC642’, for the delivery of functional RNAi molecules to the different epidermal layers of normal 
or impaired skin, without crossing the dermal compartment.    
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A Genome-wide Approach to Identify Determinants of Skin Wound Healing
B Baz,1 J Patel,1 R Ram,2 G Morahan,2 G Walker3 and K Khosrotehrani1 1 Experimental 
Dermatology Group, The University of Queensland, UQ Centre for Clinical Research, 
Brisbane, QLD, Australia, 2 The Harry Perkins Institute of Medical Research, Nedlands, 
WA, Australia and 3 Queensland Institute of Medical Research (QIMR) Berghofer, Brisbane, 
QLD, Australia
Many genes have been shown to affect wound healing in genetically modified mice. However, their 
relative importance in the healing of wild-type mice remains difficult to evaluate. Inbred wild-type 
strains show differences in their response to injury and could allow interrogating gene dose effect 
promising to be more relevant than gene knock out strategy. We aimed to perform a genome-wide 
association study of skin wound healing in murine strains. The Collaborative Cross is a mouse genetic 
panel of recombinant inbred lines derived from eight genetically diverse founders, allowing enriched 
analysis of gene pleiotropy and molecular networks. This resource captures over 90% of the known 
common genetic variation present in mice, and has been recognised as a promising tool for gene 
discovery and human disease modelling. We performed excisional wounds on 65 strains from the 
Collaborative Cross. Changes in wound surface area were recorded over the next 14 days. Strains 
were then categorised based on their healing speed (area under curve of wound surface over time) 
as a quantitative variable. There was significant heterogeneity among the strains. The most significant 
association of wound healing speed occurred on chromosome 4 (position 106,237-110,924 Mbps) 
reaching a LOD score of 8.6 and genome wide significance. In this region, C57BL/6 and A/J founder 
strain contributions were associated with fast healing. Our results indicate a phenotype-genotype 
correlation in skin wound healing. Identification of genes mediating fast wound healing will provide 
new insights towards understanding skin wound healing, potentially identifying new mechanisms 
of importance and allowing innovative therapy.    
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Rare protein-coding variants in IL36β/γ and lack of HLA asssociation in acute generalized 
exanthematous pustulosis
AA Navarini,1 MA Simpson,6 L Valeyrie-Allanore,2 P Sekula,3 F Capon,6 J Roujeau,2 
RC Trembath,4 JW Barker,1 M Mockenhaupt5 and C Smith1 1 St John’s Institute of 
Dermatology, King’s College, Division of Genetics and Molecular Medicine, London, United 
Kingdom, 2 Department of Dermatology, Referral Center for Toxic and Auto-Immune 
Blistering Diseases,, Henri Mondor Hospital, Creteil Cedex, France, 3 Institute of Medical 
Biometry and Medical Informatics, Freiburg, Germany, 4 Medical Genetics, Queen Mary 
University of London, Barts and the London School of Medicine and Dentistry, London, 
United Kingdom, 5 Dokumentationszentrum schwerer Hautreaktionen (dZh), Freiburg, 
Germany and 6 Division of Genetics and Molecular Medicine, King’s College, London, 
United Kingdom
Acute generalized exanthematous pustulosis (AGEP) is a rare severe cutaneous adverse reaction 
(SCAR). Several SCAR have been shown to be associated with certain HLA alleles. AGEP presents 
with fever and neutrophilia and shares many clinical features of generalized pustular psoriasis that is 
driven by protein-damaging IL36RN mutations. The aim of our study was to determine an association 
between AGEP and (i) HLA allotypes and (ii) rare protein-damaging genetic variants. The European 
pharmaco-epidemiologic study RegiSCAR provided DNA of 96 stringently verified AGEP cases. 
On the Illumina Omni Express platform utilizing a dense panel of SNPs across the extended MHC 
region, HLA imputation was performed in 69 European AGEP cases and 5132 ancestry-matched 
UK (WTCCC2) population controls. Subsequently, whole exome sequencing was performed. In 
imputed HLA allotypes, no significant association with AGEP was detected; however, due to limited 
sample size, we could not exclude a drug-specific HLA association. Extending previous findings 
of IL36RN mutations in AGEP, we found additional rare protein-damaging variants in the IL36 
pathway in 10 of 96 AGEP cases, namely in IL36β and IL36γ (p < 0.0004 in an Emmax burden test 
for IL36α/β/γ). Using a hypothesis-free approach across all protein-coding genes, no exome-wide 
significant association signal was identified. Taken together, these findings indicate a genetically 
distinct subset of AGEP that is closely aligned to generalised pustular psoriasis.    
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Targeted resequencing and finemapping identifies functional low-frequency missense variants 
in LRRC32 as risk factors for atopic dermatitis
E Rodriguez,1 J Manz,2 B Petersen,3 H Baurecht,1 G Mayr,3 J Harder,1 A Schwarz,1 
A Franke,3 A ElSharawy3 and S Weidinger1 1 Department of Dermatology, Venereology and 
Allergy, University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany, 2 Institute of 
Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental 
Health, Neuherberg, Germany and 3 Institute of Clinical Molecular Biology, Christian-
Albrechts-University, Kiel, Germany
Genome-wide association studies (GWAS) on atopic dermatitis (AD) and related traits consistently 
identified a common intergenic susceptibility variant on chromosome 11q13.5. Targeted rese-
quencing of the 11q13.5 region in 30 early-onset and severe AD cases and extended mutational 
screening of the coding regions of LRRC32 in 100 AD cases identified 6 low frequency missense 
single nucleotide variants (SNVs). Association analysis in 1000 AD cases vs. 1000 controls revealed 
a significant excess of these variants in individuals with AD (P=0.0007; OR 1.98). Structural protein 
modelling of GARP, the protein encoded by LRRC32, predicted these SNVs to obstruct proper 
protein folding or hamper post-translational modifications necessary for protein transport, and first 
functional overexpression assays of wildtype and mutated GARP in transiently transfected CD4+/
CD25- T-cells show a clear reduction in surface expression of the mutated protein. Our data link 
LRRC32 as causative gene to the etiopathology of AD, and strongly indicate that low-frequency 
variants in LRRC32 compromise cell surface expression of GARP.    
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Potential Benefits of Silencing the Transcription Factor FOSL1 for Controlling Psoriasis
A Mezentsev, A Zolotarenko, E Checkalin, A Shalenkov, A Soboleva and S Bruskin Functional 
Genomics, Federal Non-profit Research Institution NI Vavilov Institute of General Genetics, 
Moscow, Russian Federation
In this study, we explored potential benefits of targeting FOSL1 in psoriatic lesional skin. We 
verified whether silencing FOSL1 in immortalized human keratinocytes makes them susceptible to 
proinflammatory cytokines (TNF, IFNG and IL17), whether the parental cell line treated with the 
named cytokines exhibits a delay in cell growth and whether knocking FOSL1 down normalizes 
gene expression in hyperproliferating skin cells. Genes differentially expressed in psoriatic skin 
lesions were identified in a next generation sequencing study. Silencing FOSL1 in immortalized 
human keratinocytes (HaCaT) was achieved by lentiviral transfection. Influence of proinflammatory 
cytokines on cell growth, and migration was assessed in the corresponding in vitro assays. The ability 
of cytokines to induce FOSL1 target genes was confirmed by qPCR. Silencing FOSL1 in HaCaT 
makes them susceptible to proinflammatory cytokines. Particularly, cells treated with IFNG exhibit 
a cell growth arrest and apoptosis. Two other cytokines (TNF and IL17) enhance the biological 
effects of IFNG. Treatment of the parental cell line with a combination of TNF and IFNG delays 
the cell growth, compared to vehicle control. Silencing FOSL1 by a specific siRNA normalizes the 
expression of FOSL1 target genes, namely CCL2, FOSL1, HMOX1, IL8, IL6, IVL, MGP, MMP1, 
MMP9, and PLAUR, which are overexpressed in lesional psoriatic skin. We conclude that target-
ing the transcription factor FOSL1 can be beneficial for psoriasis for three reasons. First, silencing 
FOSL1 causes a decline in proliferation rate of hyperproliferative epidermal keratinocytes. Second, 
knocking FOSL1 down in the named cells makes them susceptible to IFNG. Third, targeting FOSL1 
is capable to normalize the expression of certain genes that are differentially expressed in psoriatic 
skin lesions and have a proven role in pathogenesis of the disease.    
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Development of a luciferase reporter system for small molecule library screening with Dow-
ling-Meara patient cell lines. 
FJ Poetschke, T Lettner, J Bauer and V Wally Department of Dermatology, Paracelsus Medical 
University, EB House Austria, Salzburg, Austria
Dowling-Meara type epidermolysis bullosa is a rare genetic disorder that manifests with severe 
blistering and erosions of the skin. No causative therapy is currently available and a lot of effort 
is invested in the search for small molecules that could ameliorate the phenotype by inhibiting 
or reducing blister formation. The search for promising candidate drugs requires the use of large 
substance libraries that are tested on patient keratinocyte cell lines. In this study we generated a 
luciferase reporter system, endogenously expressed by Dowling-Meara patient cell lines, that allows 
us to identify candidate therapeutic drugs out of hundreds of thousands of molecules. As shown in 
previous studies, Dowling-Meara patients express high levels of keratin-14 and interleukin-1 beta as 
a hallmark characteristic. It was also shown that, inhibition of interleukin-1 beta reduces keratin-14 
expression in vitro and it reduces blister formation in vivo. Therefore, it can be inferred that, the 
disease specific gene expression is under control of the keratin-14 promoter and the AP-1 response 
element. We cloned each of these two promoter elements upstream of a luciferase reporter. First 
we tested the reporter constructs transiently, and compared luciferase expression of the patient cell 
line with a wildtype control cell line, using selected interleukin-1 beta inhibitors. Then we stably 
integrated the construct into the genome of a patient cell line using the PiggyBac transposon vector 
system. The data we present in this study clearely show that, reporter expression of the keratin-14/
Luciferase and AP-1/Luciferase cell lines reflects disease specific gene expression. Small molecule 
libraries can now be tested in a large scale by comparing the luciferase luminescence signal of 
treated and untreated cells. We are confident that this tool will accelerate the identification of prom-
ising therapeutic candidate drugs, and that this will translate faster into new therapeutic approaches 
that provide benefits for Dowling-Meara patients.    
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SOSTDC1 alters TGFβ signal perception - implications for morphea disease
SJ Brown,1 B Way,1 J Harper2 and R O’Shaughnessy1 1 Infection, Immunity, Inflammation 
and Physiological Medicine, UCL Institute of Child Health, London, United Kingdom and 2 
Dermatology, Great Ormond Street Hospital, London, United Kingdom
Linear morphea (LM) is the most common form of localised scleroderma, and appears as a stripe of 
thickened skin. Affected regions show a dermal accumulation of extracellular matrix (ECM) proteins, 
primarily collagen. Current therapies involve suppressing the immune system via methotrexate, 
which gives palliative relief. Disease recurrence is common, suggesting a persistent site defect. Fibro-
blasts isolated from morphea lesions show a continued cell phenotype after removal from the ECM 
milieu, indicating they have stable cell differences that we theorise contribute to disease. One stable 
difference is the downregulation of SOSTDC1. SOSTDC1 is a secreted protein involved in antago-
nising or potentiating Wnt, BMP and TGFβ signals. It alters signalling by binding pathway compo-
nents such as BMPs, or by blocking Golgi transport of receptors. Downregulation of SOSTDC1 is 
associated with breast, renal and gastric cancers. SOSTDC1 downregulation in keratinocytes and 
fibroblasts is also significantly associated with LM lesions, and occurs in 50% of surveyed cases. 
Since SOSTDC1 can potentially regulate multiple pathways involved in fibroblast differentiation 
or ECM production, the effect of its downregulation was assessed. In mouse fibroblasts, longterm 
Sostdc1 downregulation caused an ‘activated’ phenotype, resulting in increased MMP2 production 
and activity and increased migration in scratch assays. In human cells, pre-treatment with SOSTDC1 
antibody altered the cellular perception of subsequent signals, including TGF-β1, and caused the 
fibroblast cells to switch from a dual SMAD2 and SMAD3 activation to a predominantly SMAD3 
activation upon stimulus. In fibroblasts SMAD2 and SMAD3 signals have different roles in promoting 
the expression of collagens, cytoskeletal proteins such as the myofibroblast denoting smooth muscle 
actin, and ECM remodelling enzymes. SOSTDC1 antibody treatment altered multiple aspects of 
fibroblast biology and differentiation, and thus is an attractive target for treatment in LM disease.   
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Pathological mechanisms underlying contracture formation in epidermolysis bullosa
B Liemberger,4 S Hainzl,4 U Koller,4 V Wally,1 J Pinon Hofbauer,1 A Studnicka-Benke,2 
A Diem,1 J Bauer,3 J Breitenbach1 and C Gruber1 1 Laboratory for Molecular Therapy, 
EB House Austria, University Hospital of Dermatology, Paracelsus Medical University, 
Salzburg, Austria, 2 Outpatient Unit for Rheumatology, Department of Internal Medicine 
III, SALK/Paracelsus Medical University, Salzburg, Austria, 3 Paracelsus Medical University, 
University Hospital of Dermatology, Salzburg, Austria and 4 Laboratory for Epidermolysis 
bullosa research, EB House Austria, University Hospital of Dermatology, Paracelsus Medical 
University, Salzburg, Austria
Patients with the skin blistering disease recessive dystrophic epidermolysis bullosa (RDEB) suffer 
from pseudosyndactyly and finger contractures leading to loss of hand function. The exact mech-
anisms leading to these complications are not completely understood, however loss of collagen 
type VII (C7), the root cause of RDEB, has been shown to alter the secretome of dermal fibroblasts, 
resulting in global remodelling of the tissue microenvironment. As synovial fibroblasts share many 
characteristics with dermal fibroblasts (e.g. secretion of collagens, vimentin), we hypothesized that 
changes in these cells due to COL7A1 mutations may impact the correct function of synovial tissue, 
which is essential for proper joint constitution. We confirmed C7 expression in healthy synovial 
fibroblasts (K4IM) on both the mRNA and protein level. To mimick an RDEB phenotype in K4IM 
cells, we stably knocked down C7 expression by retroviral transduction of a C7-targeting shRNA. 
Comparison of the expression profile of several pro- and anti-inflammatory cytokines, as well as 
MMPs capable of degrading synovial matrix components, in C7-deficient K4IM cells versus untrans-
duced cells demonstrated a significant increase in mRNA levels of IL8 and IL1β in C7-deficient cells. 
These results support the hypothesis that reduced C7 expression in synovial fibroblasts can impact 
their expression profile and this could subsequently alter their phenotype and function. Experiments 
are underway to investigate the condition of the joint capsules (i.e., architecture, inflammation, 
synovial fluid composition) in an animal model for RDEB.    
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Structural alterations in domains of laminin-332 β chain underlie peculiar phenotypes of 
JEB-generalized intermediate
P Fortugno,1 F Cianfarani,1 A Palmeri,2 L Guerra,1 A Diociaiuti,3 V Proto,3 G Zambruno,1 M El 
Hachem3 and D Castiglia1 1 Laboratory of Molecular and Cell Biology, Istituto Dermopatico 
dell’Immacolata (IDI)-IRCCS, Rome, Italy, 2 Centre for Molecular Bioinformatics, University 
of Rome Tor Vergata, Rome, Italy and 3 Dermatology Division, Bambino Gesù Children’s 
Hospital-IRCCS, Rome, Italy
The generalized intermediate subtype of junctional epidermolysis bullosa (JEB-gen intermed) can 
be due to an altered expression/function of laminin-332 (α3β3γ2) leading to intra-lamina lucida 
blistering. Missense or splicing mutations and, exceptionally, homozygous truncating mutations in 
laminin-332 genes cause JEB-gen intermed. We studied two patients with peculiar phenotypes of 
JEB-gen intermed. The first patient, a 12-years-old child suffering from a few persistent non-healing 
skin ulcers with prominent granulation tissue, carried the homozygous p.Gly254Asp substitution 
within the short arm of the β3 chain. Immunofluorescence mapping (IM) showed retention of 
mutant laminin-332 within basal keratinocytes, together with basement membrane alterations also 
evident by electron microscopy. The Gly254 is strictly conserved across orthologous and paralogous 
proteins and homology modeling demonstrated an impact of p.Gly254Asp on protein stability and 
local folding. The second patient, aged 63, had a history of multiple (> 20) primary squamous cell 
carcinomas of the lower extremities since his forties. IM suggested COL17A1 as candidate for genetic 
screening, however the patient was found to be compound heterozygote for nonsense mutations 
p.Arg635* and p.Cys1171* in LAMB3. The latter mutation deletes the C-terminal cysteine forming 
the interchain disulfide bond with Cys1184 of the γ2 chain. In patient keratinocytes the LAMB3 
mRNA was reduced by 50% compared to control cells and was entirely transcribed from the allele 
with the p.Cys1171* mutation. These findings show the functional hemizygosity of the patient for 
the nonsense mutation at mRNA and protein level. Our results point to the importance of struc-
tural integrity of N- and C-terminal β3 domains in laminin-332 adhesive and migratory functions.   
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Bisphosphonates Provide a Novel Treatment for Ectopic Mineralization Disorders: The Par-
adigms of PXE and GACI
Q Li,1 J Sundberg,2 M Levine,3 J Kingman1 and J Uitto1 1 Sidney Kimmel Medical College, 
Philadelphia, PA, 2 The Jackson Laboratory, Bar Harbor, ME and 3 Children’s Hospital of 
Philadelphia, Philadelphia, PA
Pseudoxanthoma elasticum (PXE) and generalized arterial calcification of infancy (GACI) are herita-
ble, currently intractable, ectopic mineralization disorders. Classic PXE and GACI cases are caused 
by mutations in the ABCC6 and ENPP1 genes, respectively, but there is considerable genotypic 
and phenotypic overlap between these two conditions. Recent studies have suggested a role for 
inorganic pyrophosphate in the development of mineralization in these disorders. In this study we 
explored the potential efficacy of bisphosphonates, stable pyrophosphate analogues, to prevent 
ectopic mineralization in two mouse models. The Abcc6-/- mice and the Enpp1 asj mice, which 
recapitulate PXE and GACI, respectively, were used as preclinical platforms. The mice were fed 
diet containing etidronate (ETD), 8 and 96 mg/kg/day, or alendronate (AST), 0.53 and 6.36 mg/kg/
day, corresponding to 1x and 12x of the doses used to treat osteoporosis in humans, respectively. 
The mice were placed on diet at 4 weeks of age, and the degree of mineralization was assessed at 
12 weeks by quantitation of the calcium deposits in the dermal sheath of vibrissae, an early and 
progressive biomarker of the mineralization process, by computerized morphometry, and by direct 
chemical assay of calcium. We found that ETD, but not AST, at the 12x dosage, significantly reduced 
mineralization, however, 1x did not have any effect. Considering the low level of absorption of 
perioral ETD (<1%), subsequent studies tested the mice with subcutaneous injections of ETD, 0.08 
and 0.96 mg/kg/day (0.01x and 0.12x). Twice weekly injections of ETD for 8 weeks resulted in 
a significant decrease in skin mineralization for both doses, as determined by calcium chemical 
assay. These changes were accompanied by alterations in the trabecular bone microarchitecture, 
determined by μCT. The results suggest that selected bisphosphonates may be helpful for prevention 
of mineral deposits in PXE and GACI.    
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Molecular mechanism underlying interstitial lung disease, nephrotic syndrome and epider-
molysis bullosa
Y He,1 E Yalcin,2 M Balasubramanian,3 R O’Reilly,3 L Bruckner-Tuderman1 and C Has1 1 
University, Freiburg, Germany, 2 University, Ankara, Turkey and 3 NHS Foundation Trust, 
Sheffield, United Kingdom
Interstitial lung disease, nephrotic syndrome and epidermolysis bullosa is a recently described, 
severe autosomal recessive multisystemic disorder associated with mutations in the ITGA3 gene, 
encoding the integrin α3 subunit. The full spectrum of clinical manifestations is still poorly charac-
terized, and genotype-phenotype correlations remain elusive. Here, we extended the spectrum of 
ITGA3 mutations and investigated the molecular disease mechanisms in two patients with severe 
fatal respiratory failure, and variable renal and cutaneous involvement. In both patients, the diag-
nosis was suggested by lack of immunoreactivity for integrin α3 in skin samples. In Patient 1, 
the homozygous mutation, c.1387C>T, p.R463W was found, which was predicted to strongly 
alter the conformation of the extracellular β-propeller domain. Analysis of the authentic protein 
extracted from the keratinocytes of the patient, demonstrated improper glycosylation and lack of 
heterodimerisation with the integrin β1 subunit. The mutant integrin α3 did not undergo maturation 
by cleavage into heavy and light chains and was not detected at the plasma membrane, behaving 
functionally like a null-mutation. In Patient 2, the homozygous mutation c.1383-11T>A, located in 
intron 9 was identified and predicted to induce a new acceptor splice site including 9 bp in frame 
(p.460_461insLLC). Analysis of the mRNA extracted from the skin sample of the patient revealed 
the precise outcome of the mutation. The usage of the aberrant acceptor splice site was confirmed 
in 30% of the 17 analyzed transcripts, while in 70% of the transcripts, complex splicing errors 
were detected, including skipping of the exons 8, 9, and 10, and partial insertion of introns 9 and 
12. Further predictions showed that c.1383-11T>A generates a new exonic splicing enhancer, 
recognized by human SRp40 binding proteins, suggesting a dual pathogenic mechanism of this 
mutation. These data underscore the crucial role of molecular studies in this new disorder, which 
may remain underdiagnosed.    
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Decrease of intra-epidermal innervation in sensitive skin
V Buhé,1 K Vié,2 C Guéré,2 A Natalizio,3 C Lhéritier,3 J Carré1 and L Misery1 1 Laboratory of 
Neurosciences of Brest, University of western Brittany, Brest, France, 2 Clarins Laboratories, 
Pontoise, France and 3 Dermscan Laboratory, Villeurbanne, France
Sensitive skin is a common disorder characterized by the occurrence of erythema and unpleasant 
sensations such as pruritus, burning or pain. Although environmental factors are known to promote 
sensitive skin, its pathophysiogeny remained unclear and no systematic immunohistochemical 
study was performed. Considering the nature of the various symptoms, we investigated the role of 
some inflammation markers and studied the intra-epidermal innervation. We blindly analysed by 
immunofluorescence the cutaneous biopsies removed from 26 non-sensitive skin female subjects 
and 24 sensitive skin female subjects that were previously enrolled using a stinging test scoring and 
a self-assessment questionnaire. Overall the evaluation of inflammation by the detection of PAR-2, 
TRPV-1 and ASIC-1 did not provide evidence of their involvement; neither did the detection of 
GPR32, which is known to take part in the resolution of inflammation. The immunostaining of the 
neuron specific protein PGP9.5 allowed us to determine the density of the intra-epidermal nerve 
fibres (IENFD). We showed that IENFD was significantly decreased in the sensitive skin group 
(non-sensitive skin group: 16.58 NF/mm of dermal-epidermal junction (DEJ), sensitive skin group: 
14.55 NF/mm of DEJ; p=0.027). The determination of the densities of the CGRP- and NF200- 
immunoreactive fibres further indicated that there was a decrease of the density of the peptidergic 
C-fibres rather than a decrease of that of Aβ fibres. While the density of the Aβ fibres was similar 
in the two groups (14.92 vs 14.94 NF/mm of DEJ), those of the CGRP-positive fibres were 7.51 
and 5.26 NF/mm of DEJ in the non-sensitive skin group and the sensitive skin group respectively 
(p=0.008). Hence, our results suggest that the pathophysiology of skin sensitivity resembles that of 
neuropathic pruritus within the context of small fibre neuropathy and that environmental factors 
may alter skin innervation.    
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Molecular diagnostics of somatic overgrowth syndromes: The emergent concept of PIK-
3CA-related overgrowth spectrum (PROS)
L Youssefian,2 H Vahidnezhad,3 Q Li1 and J Uitto1 1 Thomas Jefferson University, 
Philadelphia, PA, 2 Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic 
of) and 3 Pasteur Institute of Iran, Tehran, Iran (the Islamic Republic of)
Segmental overgrowth syndromes, a spectrum of vascular, cutaneous, and skeletal abnormalities, 
are sporadic, non-hereditary conditions and result from somatic de novo mosaic mutations in 
the PI3K/AKT/mTOR signaling pathway. These disorders include the PIK3CA-Related Overgrowth 
Spectrum (PROS). The patients with PIK3CA mutations have previously been recognized as distinct 
diagnoses, such as Fibroadipose Hyperplasia (FAH) and Megaloencephaly-Capillary Malformations 
(MCAP) syndrome. In this study we characterized four clinically challenging cases with mosaic 
overgrowth by mutation analysis in PIK3CA as the candidate gene. Two of the cases demonstrated 
macrodactyly, while one was initially diagnosed as FAH and another one as MCAP syndrome. PCR 
amplification of exons and flanking intronic sequences of PIK3CA identified missense mutations, 
p.Glu542Lys, p.Glu545Gly, p.Cys420Arg, and p.Glu453Lys in the affected tissues in respective 
cases, while analysis of DNA from adjacent normal tissue in three cases or from peripheral blood 
leukocytes in all cases revealed the wild-type allele only. In all cases, bioinformatics prediction 
programs (PolyPhen-2, and SIFT) suggested that the mutations were pathogenic, and 3-dimensional 
prediction of the consequences of the mutations by stereotypic modeling of the protein suggested 
conformational changes with deleterious consequences. Finally, the wild-type amino acid in all 
four cases was conserved during evolution in different species from Japanese pufferfish to human. 
Collectively, identification of mutations in the PIK3CA gene in these four cases with diverse phe-
notypic presentations indicated that they belong to PROS, a finding with implications for genetic 
counseling and potential treatment. Specifically, since PI3K resides upstream of AKT and mTOR 
and since rapamycin is an inhibitor of mTOR, rapamycin could be useful for treatment of these 
overgrowth syndromes at the early stages of development.    
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A fluorescence-based screening system accelerates the design of RNA trans-splicing molecules 
for mRNA repair.
T Kocher,1 U Koller,1 J Seyr,1 S Hainzl,1 E Mayer,2 G Brachtl,3 T Lener,4 J Bauer,5 V Wally2 
and E Murauer1 1 Laboratory for Epidermolysis bullosa research, EB House Austria, University 
Hospital of Dermatology, Salzburg, Austria, 2 Laboratory for Molecular Therapy, EB House 
Austria, University Hospital of Dermatology, Salzburg, Austria, 3 Institute for Experimental 
and Clinical Cell Therapy, Core Facility for Flow Cytometry, SCI-TRECS, Paracelsus Medical 
University, Salzburg, Austria, 4 University Clinic of Blood Group Serology and Transfusion 
Medicine, Core Facility for Microscopy, SCI-TRECS, Paracelsus Medical University, Salzburg, 
Austria and 5 University Hospital of Dermatology, Salzburg, Austria
Spliceosome-mediated RNA trans-splicing (SMaRT) is a promising technology to specifically replace 
one or more exons of a mutated pre-mRNA of interest. Using a fluorescence-based screening system 
we have identified efficient RNA trans-splicing molecules (RTMs) for the genes COL7A1, COL17A1, 
PLEC and K5, in which mutations cause different types of the severe skin disease epidermolysis 
bullosa (EB). We have generated a model system which allows us to easily analyse individual 
RTMs for several EB variants. In order to obtain reliable and reproducible results we have improved 
our previously developed fluorescence-based RTM screening model by generating stable HEK-
293 target celllines, expressing minigenes including the mutations of the above mentioned genes, 
respectively. We have transfected these target cell lines with RTMs consisting of randomly generated 
binding domains for the respective targets. Sequence analysis of RTM binding domains which are 
predominantly expressed in GFP positive cell populations, revealed a tendency of preferred target 
regions for RTM binding. We assume that these regions represent promising binding sequences 
for efficient trans-splicing, which could be confirmed in endogenous RNA-repair approaches in 
dermal human keratinocytes. Selected RTMs will now be adapted for therapeutic RNA repair in 
patient cells. Our screening system facilitates the construction of highly functional RTMs prior to 
endogenous RNA-repair approaches.    
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A proteomic screen for alterations in psoriasis
E Szél,1 R Bozó,1 É Hunyadi-Gulyás,2 B Gál,1 N Belso,1 K F. Medzihradszky,3 L Kemeny,1 
Z Bata-Csorgo1 and G Groma1 1 Department of Dermatology and Allergology, University 
of Szeged, Faculty of Medicine, Szeged, Hungary, 2 Biological Research Centre, Szeged, 
Hungary and 3 Department of Pharmaceutical Chemistry, University of California, San 
Francisco, CA
In order to gain further insight into the changes present in psoriatic non-lesional and lesional skin, 
we applied a solubility-based, multi-step protein extraction followed by high-pH chromatography 
and LC-MS/MS analysis for protein identification comparing healthy, non-lesional and lesional 
skin. Altogether, our analysis resulted in the identification of over 2300 different proteins out of 
which 203 proteins were only found in healthy skin. 59 proteins were detected exclusively in the 
non-lesional and 249 were characteristic only for lesional samples, whereas 73 proteins were found 
in both psoriatic samples, but not in healthy controls. Based on text mining, among proteins showing 
at least two-fold changes in psoriatic non-lesional and lesional skin compared to healthy skin, we 
identified many alterations already described in the literature, in good agreement with the current 
concept of the pathomechanism of the disease. We also found some possible novel alterations not 
yet been associated with psoriasis. Many of these novel changes may take place already in the non 
lesional skin or triggered upon inflammation in the lesional skin (at least 2.6 and 1.1% of identified 
proteins, respectively). Most of the novel abnormalities detected at the protein level are likely to play 
a role in the mechanism of the disease, since these molecules are important in several major cellular 
processes influencing cell proliferation, differentiation, migration, lipid metabolism, extracellular 
matrix deposition and immune responses.    
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Epidermolysis bullosa associated with an autosomal dominant ITGB4 mutation diagnosed by 
targeted next-generation sequencing
I Turcan,1 AM Pasmooij,1 PC van den Akker,2 H Lemmink2 and MF Jonkman1 1 Dermatology, 
University Medical Centre Groningen, Groningen, Netherlands and 2 Genetics, University 
Medical Centre Groningen, Groningen, Netherlands
Epidermolysis bullosa (EB) is a group of mechanobullous genodermatoses characterized by the 
fragility of skin and mucous membranes. Mutations in ITGB4 and ITGA6 genes, encoding the 
hemidesmosomal protein integrin α6β4, have been involved in the pathogenesis of EB. Up to 
date, the inheritance of these particular genes is known to be exclusively autosomal recessive. 
The objective of this study is to report a novel heterozygous mutation in ITGB4 with a dominant 
negative effect co-segregating in an extended family with EB phenotype. A diagnostic next genera-
tion sequencing gene panel test based on targeted exome sequencing of genes associated with EB 
revealed a heterozygous missense mutation in exon 5 of the ITGB4 gene: c.433G>T, p.Asp145Tyr. 
Results were subsequently confirmed by means of Sanger sequencing of genomic DNA. Residue 
p. Asp145Tyr in the extracellular domain is highly conserved between species. This mutation has 
not been previously described in the literature and predicted pathogenic. The phenotype of affected 
individuals is primarily characterized by nail dystrophy, and late-onset mild acral blistering after 
puberty. Some individuals also developed hypergranulation tissue in the larynx, urethra or external 
ear channel. This study highlights the possibility of dominant mode of inheritance for an ITGB4 
gene mutation. Furthermore, it yields information on the natural history of this particular mutation 
in later life, with prognostic repercussions for younger patients, such as acral blistering after puberty.   
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Single amino acid deletion in kindlin-1, p.R100del affects protein folding and results in an 
intermediate KS phenotype
K Maier, Y He, K Thriene, L Bruckner-Tuderman, J Dengjel and C Has University, Freiburg, 
Germany
Kindler syndrome is a rare autosomal recessive distinct type of epidermolysis bullosa, caused by 
mutations in FERMT1, encoding kindlin-1. Most FERMT1 mutations lead to premature termination 
codons and absence of kindlin-1. Here we investigated the molecular and cellular consequences of 
a naturally occurring FERMT1 mutation, resulting in a single amino acid deletion, p.R100del. The 
mutation led to a 50% reduction in FERMT1 mRNA, and only 10% kindlin-1 in the keratinocyte 
line, KSKR100del, derived from the patient, as compared to the control cell line from a healthy donor. 
The low kindlin-1 levels were sufficient to improve the cellular phenotype of KSKR100del in respect 
to spreading and proliferation as compared to kindlin-1 negative keratinocytes. These findings 
correlated with in situ findings in the skin of the patient, which demonstrated proper deposition of 
dermal-epidermal junction proteins and Ki-67 positive basal keratinocytes comparable with the con-
trol skin. To understand the consequences of p.R100del, we performed structural predictions which 
indicated misfolding, in particular of the polylysine loop, which is important for lipid-binding and 
integrin coactivation. We found that kindlin-1R100del undergoes lysosomal degradation. In the attempt 
to improve folding, the cells were treated with sodium phenylbutyrate. This increased kindlin-1R100del 
on mRNA and protein levels significantly, suggesting that in this case, sodium phenylbutyrate acts 
as a histone deacetylase inhibitor rather than a chemical chaperone. Our findings suggest that the 
mutation p.R100del is associated with reduced mRNA and low protein levels due to misfolding 
and lysosomal degradation. The impact of the mutation on the molecular interactions of kindlin-1, 
remains to be established. Importantly, the patient and the KSKR100del keratinocytes demonstrated 
an alleviated phenotype compared with null mutants. The study of this hypomorphic mutation has 
therapeutic relevance, providing the first evidence that low amounts of truncated kindlin-1 are 
sufficient to improve the phenotype.    
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Acetate potentiates pro-inflammatory responses to TNFα/IL-17 through epigenetic modifi-
cations: a potential role in alcohol-provoked psoriasis
KC Wu,2 NR Harker,1 SF Kendrick,1 MJ Donaldson,1 MA Morse1 and NJ Reynolds2 1 
GlaxoSmithKline, Stevenage, United Kingdom and 2 Newcastle University, Newcastle Upon 
Tyne, United Kingdom
Psoriasis represents a complex interplay between genetic predisposition, the environment and 
inflammatory responses. TNFα and IL-17 synergistically regulate key cytokines involved in psoriasis 
pathogenesis including IL-6/-8 mRNA production by keratinocytes (KCs). Alcohol is a risk factor 
for the development and exacerbation of psoriasis and is known to potentiate macrophage IL-6 
production through epigenetic mechanisms in an alcoholic liver disease model. As KCs do not 
metabolise ethanol, we hypothesised that acetate, a principle metabolite of ethanol, may potentiate 
expression and secretion of IL-6/-8 and that acetate may act through chromatin remodelling, facilitat-
ing hyperacetylation and thus promoting gene expression. Primary human KCs were incubated with 
clinically relevant concentrations of acetate (0.2-1mM), for 7 days prior to stimulation with TNFα/
IL-17. Acetate treatment resulted in concentration-dependent potentiation of IL-6 expression, but 
not IL-8, in response to TNFα/IL-17 stimulation compared to control (1mM acetate; p<0.05 for IL-6 
mRNA, qPCR; p<0.05 for secreted IL-6, ELISA/Meso Scale Discovery® platform). Chromatin immu-
noprecipitation studies showed that TNFα/IL-17 stimulated an increase in active epigenetic epitopes, 
including acetylation of lysine 27 on histone H3 (H3K27ac), and corresponding recruitment of pol 
II to IL-6/-8 promoter regions. Acetate (1mM) significantly enhanced the TNFα/IL-17 stimulated 
increase in active epigenetic epitopes (e.g. H3K27ac) and pol II recruitment to the IL-6 promoter, but 
not to the IL-8 promoter, in keeping with acetate’s differential effects on IL-6/-8 responses to TNFα/
IL-17. Acetate’s enhancement of pro-inflammatory responses, through epigenetic modifications, 
may explain how alcohol predisposes patients to an exaggerated inflammatory response resulting in 
exacerbation of their psoriasis. Moreover, these data provide mechanistic insight into the regulation 
of cutaneous inflammation by defined environmental signals.    
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Contribution of mechanical stress to impaired differentiation and proliferation of lesional 
keratinocytes in striate palmo-plantar keratoderma caused by haplo-insufficiency of DSG1
D Utsumi, H Uezato and K Takahashi Dermatology, University of the Ryukyus, Nakagami, 
Japan
Striate palmo-planter keratoderma (sPPK) is a rare hereditary keratoderma characterized by linear 
or focal hyperkeratosis on physically stressed palm and sole skin, and caused by mutation of 
desmoglein1 (DSG1) or desmoplakin (DSP) gene. Here, we report a Japanese family with sPPK 
who presented linear or focal thickening of palm and sole skin, respectively. Genomic analyses 
of DSG1 of each affected kindred disclosed a single nucleotide deletion c.489delA in one allele, 
which leads to the truncation at the extracellular domain of DSG1. Histologically, the slightly 
widen intercellular spaces at spinous layer, the detachment at the tri-cellular junction at the gran-
ular layer and the characteristic marked hyperkeratosis of cornified layer were observed without 
any acantholytic phenotypes. In lesional skin, the expressions of keratins and related proteins vary 
alternately in accordant with sulci and cristae cutis in a stripe-like pattern. The K9, K2e and loricrin 
were particularly expressed in cristae cutis, whereas K14, K16, involucrin and DSG3 were more 
obvious in sulci cutis. The basal cell proliferation proved by ki67 expression is primarily restricted 
in cristae but not in sulci cutis. Recently, DSG1 is suggested to govern the intracellular signals and 
to induce epidermal differentiation by inhibiting ERK phosphorylation through ERBIN. Indeed, in 
our case, the expression of phosphorylated ERK (pERK) was decreased in cristae cutis in contrast 
to the increase in sulci cutis. The intercellular spaces in granular layer in the lesional sulci cutis 
was significantly larger than that in cristae, indicating the load of higher pressure forced on sulci. 
The distinct expression of pERK between sulci and cristae can contribute to the peculiar stipe like 
keratinization. Consequently, sole skin may have the vertical stripe like differentiation in addition 
to the general horizontal differentiation.    
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Mathematical investigation of the mechanisms underlying the gradual aggravation of atopic 
dermatitis and its prevention 
E Domínguez-Hüttinger and R Tanaka Imperial College London, London, United Kingdom
This study aims to elucidate the system-level mechanisms of the gradual aggravation of atopic 
dermatitis (AD) and to provide a mathematical basis to evaluate the effectiveness of preventive 
treatments to halt the progression from mild to severe forms of AD. The effectiveness of early treat-
ment strategies for AD is currently limited by the lack of mechanistic understanding of the complex 
AD pathogenesis. The complexity stems from the fact that AD can be caused by multiple factors, 
including filaggrin deficiency and environmental aggressors that cause a defective skin barrier 
function and inflammation. Moreover, strong immune responses reduce the barrier function, further 
increasing the infiltration of environmental aggressors that trigger more immune responses. This 
complex interplay underlies the gradual aggravation of the disease phenotype, and its understanding 
requires quantitative and systems-level analysis. We developed the first mathematical model of AD 
to elucidate this complex interplay. Computational simulation of the developed model enables us 
to systematically and extensively explore the effects of different combinations of the main genetic 
and environmental risk factors predisposing to AD, including different levels of filaggrin deficiency 
and hapten exposure, on AD progression of virtual patient cohorts. As a result, we mathematically 
identified the critical doses and combinations of risk factors that can result in the gradual aggravation 
of the disease, demonstrated why frequent but mild episodes of loss of skin barrier function and 
inflammation may lead to a dramatic worsening of the AD phenotype in some patients, and proposed 
early intervention strategies that effectively hinder the progression of AD. Our mathematical model 
of AD provides a mechanistic, integrative and quantitative framework that can inform new and more 
effective treatment strategies that prevent the gradual disease aggravation of AD.    
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EV causing splice site mutation in TMC8 leads to several aberrant splice products
E Imahorn,1 I Spoerri,1 Z Yüksel,2 W Kempf,3 PH Itin4 and B Burger1 1 Department of 
Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland, 2 Medical 
Genetics Department, Eskisehir Osmangazi University, Eskisehir, Turkey, 3 Kempf and Pfaltz 
Histological Diagnostics, Zürich, Switzerland and 4 Dermatology, University Hospital Basel, 
Basel, Switzerland
Epidermodysplasia verruciformis (EV) is a rare recessive genodermatosis associated with a high 
susceptibility to infections with certain types of HPV (EV-HPV) and an increased risk for development 
of cutaneous squamous cell carcinomas (cSCC) on UV exposed skin. While EV patients infected by 
EV-HPV develop wart-like lesions already during childhood, asymptomatic infections at much lower 
virus copy numbers per cell are common in the general population. The majority of EV-patients 
are carriers of homozygous or compound heterozygous mutations in either the TMC6 or the TMC8 
gene. In most cases, these changes are nonsense or frameshift mutations leading to a loss of the 
affected protein. Earlier, we presented a homozygous splice-site mutation within the TMC8 gene in 
a large family with at least three children clinically diagnosed with EV and EV-HPV present in their 
lesional skin. Nothing is known about the effect of splice-site mutations in both TMC. Therefore, we 
analyzed cDNA of all affected children and both parents. Quantitative PCR revealed no significant 
difference in the amount of TMC8 cDNA in the parents or affected children compared to healthy 
controls. In the affected children however, several aberrant splice products could be detected; the 
parents additionally showed the wild-type splice product. Unfortunately, proteins of patients were 
not receivable for examination. In conclusion, the presented splice-site mutation does not lead to a 
nonsense-mediated decay of the mRNA but results in many different aberrant splice products. None 
of them seems to be capable of restoring a complete healthy phenotype. Follow-up of the patients 
might point out influences of the aberrant products on the severity of the disease.    
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Increased prevalence of filaggrin deficiency in recessive X-linked ichthyosis
K Süssmuth,1 R Elke,2 A Sánchez-Guijo,3 N Straub,1 H Traupe,1 D Metze,1 S Schneider,4 
I Hausser-Siller,5 S Weidinger2 and V Oji1 1 University of Münster, Münster, Germany, 2 
University of Kiel, Kiel, Germany, 3 Justus-Liebig University, Giessen, Germany, 4 University 
of Mannheim, Mannheim, Germany and 5 University of Heidelberg, Heidelberg, Germany
Recessive X-linked ichthyosis (RXLI) is a keratinization disorder caused by a deficient activity of 
human enzyme steroidsulfatase. In contrast ichthyosis vulgaris is due to semidominant mutations 
of the filaggrin gene(FLG). Clinically it may be difficult to distinguish both disorders, moreover 
some case reports show a coincidence of RXLI and filaggrin deficiency. We wanted to examine the 
prevalence of FLG mutations in RXLI and correlate their effect on disease severity. Therefore we 
performed a prospective study, confirmed biochemically RXLI in 36 patients and analyzed them for 
the five most common FLG mutations (R501X, 2282del4, R2447X, S3247X, 3702delG). Mutations 
have been typed by restriction enzyme and TaqMan allelic discrimination assays. Histology, ultra-
structural analyses as well as FLG mapping have been done for several patients. In the overall group 
(n=36) 16 patients had been suspected to suffer from concomitant filaggrin deficiency, e.g. due to 
atopy, palmoplantar hyperlinearity or elevated IgE levels. FLG mutations have been confirmed in 
8 patients. One patient was compound heterozygous for the mutations R501X and 2282del4 and 
clinically showed a severe ichthyosis. In this small collection of RXLI cases the frequency of FLG 
mutations was surprisingly high (>20% compared to 10% in the population).The increased FLG rate 
may be explained by higher disease severity, e.g. skin infections, which might have influenced the 
recruitment of patients with RXLI+FLG deficiency. However, some patients with RXLI were severely 
affected by the ichthyosis and showed atopic manifestations, but did not show a FLG mutation. 
This study may lead to a better understanding of these two types of ichthyosis and their differential 
diagnosis. The differences of disease expression suggest that FLG deficiency is an important genetic 
modifier of RXLI, but there might be other factors influencing the disorder that are not known yet.   
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Micro-RNA signatures in recessive dystrophic epidermolysis bullosa
R Zauner, M Wimmer, J Bauer, T Lettner and V Wally University Hospital Salzburg, 
Paracelsus Medical Univerity Salzburg, EB House Austria, University Clinics of Dermatology, 
Salzburg, Austria
Epidermolysis bullosa (EB) is a devastating disease of the skin and mucous membranes. Among 
the different subtypes, recessive dystrophic EB (RDEB) is the most severe one. Patients present with 
generalized blistering and a number of secondary manifestations. RDEB is diagnosed in 28% of all 
EB cases and accounts for the majority of premature deaths. Of those, nearly all are the consequence 
of aggressive squamous cell carcinomas (SCCs), which usually arise in the patient’s third or fourth 
decade of life. The underlying mechanisms leading to tumor development in this patient group are 
still not fully understood. As misregulation of non-coding RNAs is well known to be involved in 
tumor development, we are investigating epigenetic events in RDEB keratinocytes, fibroblasts and 
carcinoma derived cells, with the aim of identifying regulated miRNAs that are potentially involved 
in disease progression. We performed miRNA- and gene expression microarrays of six different 
RDEB cell lines, revealing a high number of regulated miRNAs and mRNAs. Further, we analyzed 
hsa-miR711, which is encoded within exon 62 of the RDEB underlying COL7A1 gene. We found, 
that miR711 as well as its target CD44 are differentially regulated in RDEB cell lines. These data 
provide new insights into RDEB related pathomechanisms and might reveal novel therapeutic targets 
for future treatments of RDEB.    
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Deciphering of molecular events occurring in keratinocytes upon solar simulated radiations
S Rouanet, Y Gache, M Goncalves-Maia, SI Al-qaraghuli, F Pedeutour and T Magnaldo 
IRCAN, Nice, France
Xeroderma pigmentosum (XP) is a rare, recessive genodermatosis characterized by high photo-
sensitivity and susceptibility to the development often before the age of 8 of malignant epidermal 
carcinomas in photo exposed skin, in absence of photoprotection, leading to compromised health 
conditions and life expectancy. This disease is due to defective nucleotide excision repair of DNA 
lesions occurring upon solar radiation. XP-C is the most frequent form of the disease in our countries. 
In our laboratory, we use XP-C primary skin keratinocytes to model genomic hypermutability as 
well as molecular and cellular events leading to aggressive cutaneous cancers. As chronic solar 
irradiations are responsible for the majority of SCC, which relative frequency is much higher in XP 
patients than in general population, we analyzed the effects of chronic solar simulated radiations 
(SSR) on WT and XP-C keratinocytes in culture, using chronic low dose of single SSR per week for 
8 weeks (100 J UVB/m2). We have shown the emergence of atypical clones of XP-C keratinocytes 
populations while SSR irradiation of WT cells resulted in clonal transition. Atypical clones exhibited 
significant increase in growth and clonogenic potential compared to the WT suggesting a selective 
advantage of growth after iterative irradiation (IRR) of XP-C cells (from 10% after 4 IRR to 25% after 
8 IRR). Karyotype analyzes of XP-C clones revealed normal chromosomal distribution, suggesting 
occurrence of point mutations rather than gross genetic rearrangement. Cell cycle analyses of those 
clones showed higher rates of cells in G2/M phases. We are currently analyzing 1) the genetic status 
of 400 oncogenes and tumor suppressor genes frequently mutated in tumor cells, and 2) the patterns 
of gene expression in those clones. Deciphering molecular and cellular modifications occurring 
in cells during iterative exposure toward UV carcinogenesis will be a great help to better diagnose 
the evolution of skin cancers and to develop drugs targeting the specific pathways affected in both 
XP patients and in individuals of the general population.    
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The altered expression of splicing factors in non-involved psoriatic epidermis contributes to 
the synthesis of the EDA+ fibronectin isoform and to enhanced keratinocyte responsiveness
E Szlavicz,1 K Szabo,1 Z Bata-Csorgo,1 A Bebes,1 G Groma,1 L Kemeny1 and M Szell2 1 
Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary and 2 
Department of Medical Genetics, University of Szeged, Szeged, Hungary
We have previously shown that the fibronectin isoform containing the alternatively spliced EDA 
domain (EDA+ fibronectin) is overexpressed by keratinocytes derived from psoriatic non-involved 
epidermis. We suggested that this fibronectin isoform plays a key role in the altered keratinocyte 
responsiveness to T-lymphokine stimuli. In another set of experiment we aimed to identify novel 
factors contributing to the enchanced responsiveness of psoriatic non-involved epidermis. Among 
the 71 transcripts showing alterered expression, our cDNA microarray experiment identified three 
genes, serine/arginine-rich splicing factor 18 (SFRS18), peptydilpropyl isomerase G (PPIG) and luc-7 
like3 (LUC7L3), all known as regulatory factors participating in mRNA maturation processes. We 
aimed to investigate whether these splicing regulators are implicated in the regulation of fibronec-
tin mRNA splicing. For that, immortalized keratinocytes (HPV-KER) were transfected with siRNA 
constructs silencing the LUC7L3, PPIG and SFRS18 regulators alone and in combination and the 
EDA+/total fibronectin ratio was measured. The most significant changes of fibronectin mRNA 
expression patterns have been detected upon silencing of LUC7L3 alone and upon the combined 
silencing of LUC7L3/SFRS18. The amount of EDA+ fibronectin and total fibronectin was detected by 
flow-cytometry using this double silenced (LUC7L3/SFRS18) experimental set-up and we found that 
the EDA+ isoform was significantly decreased, while the amount of total fibronectin was unchanged. 
Our results indicate that the identified splicing factors are involved in the regulation of fibronec-
tin mRNA splicing, thus their altered expression may contribute to the synthesis of the of EDA+ 
fibronectin isoform in keratinocytes.    
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S100A8 promoted Th1-related gene expression and S100A9 induced Th2 differentiation via 
activation of GATA-3
T Hibino,1 M Miyai,2 S Nakajima,3 M Yamamoto-Tanaka,1 T Maeda,1 M Sakaguchi,2 
K Kabashima3 and R Tsuboi1 1 Dermatology, Tokyo Medical University, Tokyo, Japan, 2 
Cell Biology, Okayama University Graduate School of Medicine, Okayama, Japan and 3 
Dermatology, Kyoto University, Kyoto, Japan
Transcription factor GATA-3 is essential for the Th2 differentiation and also plays important roles in 
keratinocyte differentiation. Since activation of GATA-3 is dependent on p38 MAPK, we examined 
whether S100A9 was capable to induce p38 phosphorylation via its receptor EMMPRIN. Indeed, 
S100A9 phosphorylated p38 and knockdown of EMMPRIN abolished this effect. S100A9 and its 
partner molecule, S100A8 was highly up-regulated in the air exposed keratinocytes and externally 
added S100A9 or S100A8/A9 (calprotectin) promoted GATA-3 phosphorylation in cultured keratino-
cytes and its translocation into the nuclei. In contrast, S100A8 did not show any effect on the GATA-3 
activation. S100A9 was hardly detectable in normal epidermis, whereas it was strongly up-regulated 
in the lesional skin with atopic dermatitis (AD). Interestingly, GATA-3 was accumulated in the nuclei 
with S100A9-positive cells. Also strong staining of EMMPRIN was usually found in the upper epi-
dermis of the lesional skin. Microarray analysis of S100-treated murine bone marrow-derived cells 
(BMDC) demonstrated that externally added S100A8 and S100A9 induced multiple genes involved 
in the Th1 differentiation pathway. Difference between S100A8 and S100A9 was demonstrated 
in the genes with IFN-related pathway. S100A8 but not S100A9 markedly affected genes in this 
pathway. Involucrin promoter-driven S100A8 transgenic mouse (Tg) showed distinctive induction 
of IFN-gamma mRNA in the TNCB-treated skin. On the other hand, in the skin with S100A9 Tg 
mouse, we observed strong IL-4 gene induction after topical SDS application. Collectively, these 
results suggest that S100A8 has the ability to drive Th1 pathway in the transcriptional level, and 
S100A9 promotes Th2 differentiation in the post-transcription level. Since S100A9 is dominantly 
expressed in the skin with AD, S100A9 would play a critical role in the patho-physiology of AD.   
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Accelerated calcification in fibroblasts derived from Pseudoxanthoma elasticum-like disorder, 
GGCX syndrome
Y Okubo,1 A Iwanaga,1 S Ikehara,1 R Masuyama2 and A Utani1 1 Dermatrogy, Graduate 
School of Biomedical Science, Nagasaki university, Nagasaki, Japan and 2 Molecular Bone 
Biology, Graduate School of Biomedical Science, Nagasaki university, Nagasaki, Japan
Pseudoxanthoma elasticum (PXE)-like symptoms with multiple coagulation deficiency is found in 
GGCX syndrome, caused by gamma-glutamyl carboxylase (GGCX) gene mutation. GGCX is an 
enzyme that carboxylates glutamate residues in a group of proteins including anti-calcification 
molecules (e.g., matrix Gla protein (MGP) or osteocalcin, periostin, and Gla-rich protein), vita-
min K-dependent coagulation factors (factor,,, ), protein C, protein S and protein Z, and growth 
arrest-specific protein6 (Gas6). We reported a 55- year old Japanese male with PXE-like phenotype 
such as cutis laxa, calcification of elastic fibers in the dermis, peripapillary atrophy of the retina, and 
coagulation insufficiency because of homozygous deletion of T at near C-terminal end, producing 
82-amino acid larger GGCX. His parents are consanguineously married. By western blotting, GGCX 
molecule of the cultured patient’s fibroblasts was expectedly larger than that of normal fibroblasts, 
but its protein level was similar to control. Immunocytochemistry demonstrated that localization 
of the mutated GGCX molecule was similar to that of control’s. To reveal functional abnormality, 
we performed in vitro calcification assay using fibroblasts. The patient’s fibroblasts cultured for 21 
days under osteogenic conditions showed more calcifications, confirmed by von Kossa and Alizarin 
red positive stainings. These observations suggest that GGCX dermal fibroblasts itself may be able 
to recapitulate aberrant calcification of elastic fibers in the dermis.    
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Modelling X-linked recessive ichthyosis in vitro
FT McGeoghan,1 P Derwin,1 M Caley,1 MJ Donaldson2 and E O’toole1 1 Queen Mary 
University of London, London, United Kingdom and 2 Stiefel, a GSK Company, London, 
United Kingdom
X-Linked Recessive Ichthyosis (XLRI) results from a deficiency of the enzyme steroid sulfatase (STS) 
and is characterised by an accumulation of cholesterol sulfate in the upper layers of the epidermis, 
resulting in a scaling phenotype and barrier dysfunction. In this study we produced 3 cell lines with 
stable knockdown of STS in a telomerase-immortalized keratinocyte line using different lentiviral 
shRNA clones to create a 3D in vitro model of XLRI. Knockdown was confirmed by western blot-
ting, qPCR and immunofluorescence and the cell lines were characterised by migration, adhesion 
and viability assays. Loss of STS had no significant effect on migration, adhesion, or viability. 3D 
organotypic models were generated and loss of STS caused acanthosis of the epidermis and altered 
differentiation as assessed by cytokeratin 10 and involucrin antibodies. In order to further analyse 
the role of STS in cellular processes in the skin, we performed RNA-Seq analysis of the transcriptome 
of keratinocytes with loss of STS. Input of upregulated genes into Panther, a program to examine 
altered pathways, showed overenrichment of genes involved in integrin signaling, angiogenesis 
and axon guidance. Input of downregulated genes drew our attention to pathways involved in 
sex hormone biosynthesis, which is of interest given the association of XLRI with hypogonadism. 
A subgroup of genes were identified with retinoic acid response elements. In summary, the 3D 
organotypic model simulated the expected phenotype in vivo and is suitable to further characterize 
novel treatments of XLRI.    
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Mutation database and novel mutations in Darier Disease and Hailey-Hailey Disease
R Nellen,1 P Steijlen,1 J Frank,2 M van Steensel3 and M van Geel1 1 Dermatology, MUMC, 
Maastricht, Netherlands, 2 Dermatology, UKD, Düsseldorf, Germany and 3 Dermatology, 
University of Dundee, Dundee, United Kingdom
Darier Disease, defined by warty papules in seborrheic and flexural areas, is caused by mutations 
in the ATP2A2 gene. The ATP2C1 gene is associated with Hailey-Hailey Disease, with vesicles and 
erosions in flexural skin as major symptoms. Both genes encode different ATP dependent pumps, 
transporting Ca2+ or Ca2+/Mn2+ from the cytosol to the lumen of the endoplasmic reticulum (SERCA2) 
or the Golgi (SPCA1) respectively. However, 12-40% of DD patients and 12-55% of HHD patients 
do not show mutations in ATP2A2 and ATP2C1. We created a database for all mutations in ATP2A2 
and ATP2C1 reported in the literature using the Leiden Open Variation Database (LOVD v2.0). 
The current entry for variations of ATP2A2 holds 331 entries with 235 unique variants, for ATP2C1 
190 entries with 148 unique variants. The variants for both genes are located throughout the genes 
and include missense, nonsense, frameshift deletion and duplication, and splice site mutations. 
We add 58 unreported cases of DD and 18 cases of HHD. We found 40 ATP2A2 mutations (69%) 
and 14 ATP2C1 mutations (78%) in the patients with DD and HHD respectively. Mutations are 
scattered throughout the genes and are in all mutation categories. Of the ATP2A2 mutations, 26 
are novel, for ATP2C1 mutations, 11 are novel. We provide the first comprehensive review of all 
reported mutations in ATP2A2 and ATP2C1. All types of variants are found and are distributed in 
all coding sequence of both genes. A clear phenotype-genotype relationship has not been noted in 
DD and HHD. In both disorders, the phenotype may vary in patients affected by the same mutation. 
However, in DD there is data suggesting that mutations in the ATP-binding region of SERCA2 are 
associated with the development of Acrokeratosis Verruciformis of Hopf. In DD and HHD patients 
with no mutation in the associated gene, variants may be present in gene regions not screened (e.g. 
deep intronic, promoter regions), exon deletions or duplications, or the phenotype could resemble 
DD or HHD, but is caused by other gene defects.    
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The gene abnormal methylation in parapsoriasis
V Mitroshina,1 N Potekaev,2 D Zaletaev3 and I Khamaganova1 1 department of skin diseases 
& cosmetology, Pirogov Russian national research medical university, Moscow, Russian 
Federation, 2 Health Department, Moscow, Russian Federation and 3 Sechenov First moscow 
state medical university, Moscow, Russian Federation
Parapsoriasis is a group of rare dermatoses known to be a possible precusor of cutaneous T- cell 
lymphoma(CTCL).The epigenetic regulation of gene activity which is based on abnormal methyla-
tion/demethylation may be essential in cancerogenesis.The disbalance of methylation was shown 
in neoplastic cells.Abnormal methylation of the promoter CpG islands takes place simultaneously 
with genome hypomethylation.The result is inactivation of the gene expression.The same type of 
methylation was described on genes which take part in the apoptosis,angiogenesis,signal transduc-
tion,DNA repair,metastatic process,detoxication,drug resistance.So, gene can be totally inactivated 
without any structural changes of nucleotide sequence.The abnormal methylation was detected in 
CTCL patients.The objective of the study was to examine abnormal methylation of gene regulatory 
loci (promoter regions) in small plaque and large plaque PP.Abnormal methylation of genes involved 
in cancerogenesis(RASSF1A,MLH1,P16,GSTP1,RARβ,N33,CDH1,ESR,P21,CAV,CD44,MGMT,G-
PX3,RB1,P14)was examined in17 patients with PP(11- with large plaque PP,6- with small plaque 
PP)Methods of abnormal methylation investigation on gene promoter regions were methylation- 
sensitive or methylation specific PCR.2 patients with large-plaque PP had abnormal methylation on 
some genes .Both had abnormal methylation of P16&CD44,in 1- methylation of P21& RAASF1A 
was detected as well.In 1 patient with small plaque PP methylation with RB1 was detected.So, the 
abnormal methylation was detected in PP patients.Further investigation is necessary for obtaining 
reliable statistical data in order to decide whether abnormal promoter methylation of some genes 
involved in cancerogenesis can be used as a predicitive markers for prognosis of CTCL development   
362
Value of Immunohistochemistry in the Subtyping of Autosomal Recessive Congenital 
Ichthyose
K Vesely,1 M Hermanova,1 L Fajkusova,2 H Buckova,3 M Vesela1 and R Borska2 1 1th 
Department of Pathological Anatomy, St. Anne’s University Hospital in Brno, Brno, Czech 
Republic, 2 Centre of Molecular Biology and Gene Therapy, University Hospital Brno, Brno, 
Czech Republic and 3 Department of Pediatric Dermatology, University Hospital Brno, Brno, 
Czech Republic
Autosomal recessive congenital ichthyoses (ARCI) are a heterogeneous group of disorders of epi-
dermal cornification caused by mutations in 9 genes involved in the lipid metabolism, namely 
TGM1 coding transglutaminase 1; ABCA12 coding ATP-binding cassette, subfamily A, member 
12; NIPAL4 coding NIPA-like domain-containing 4; CYP4F22 encoding cytochrome P450, family 
4, subfamily F, polypeptide 22; ALOX12B coding 12-lipoxygenase, R type; ALOXE3 coding lipox-
ygenase-3; PNPLA1 coding patatin-like phospholipase domain-containing protein 1; LIPN coding 
lipase family, member N; and CERS3 coding ceramide synthase 3. The aim of the study was to 
correlate immunohistochemical expression ALOX12B and ABCA12 with the result of the mutational 
analysis in the attempt to implement fast and simple method for guiding mutational analysis in cases 
of ARCI. Classical mutation analysis of the TGM1, ALOX12B, ALOXE3, NIPAL4, and CYP4F22 
genes (PCR-sequencing) and Sequence Capture and Targeted Resequencing (SeqCap-TR) of all 
known genes associated with ichthyosis were performed in the cohort of 33 patients. Skin biopsy 
samples of 10 patients were available for immunohistochemical analyses by immunoperoxidase 
method. Absent or markedly reduced immunohistochemical expression of ALOX12B was observed 
in the ARCI cases with ALOX12B and TGM1mutations. Expression of ALOX12B was retained in 
the subgroup of ALOXE3, ABCA12, NIPAL4, and CYP4F22 mutations. Expression of ABCA12 was 
significantly reduced in 2 cases with ABCA12 mutation. The results indicate that the immunohisto-
chemical analysis on skin biopsy samples can be valuable adjunct to directing mutational analysis 
and molecular classification of ichthyoses    
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COL7A1 mutations in recessive dystrophic epidermolysis bullosa patients identified by next 
generation sequencing inherited diseases panel
B Mayer,1 P Sillo,1 T Szemes,2 M Hýblova,2 D Pinter,1 M Mazan1 and S Kárpáti1 1 
Semmelweis University, Budapest, Hungary and 2 Comenius University, Bratislava, Slovakia
Our aim was to identify mutations in the COL7A1 gene in recessive dystrophic epidermolysis 
bullosa patients and to look for further genetic changes in genes that encode proteins along the 
basement membrane and could potentially modify disease phenotype interacting with collagen 
VII. Four patients (1 female, 1 year old; 3 males, 8, 10 and 54 years old) were diagnosed hav-
ing severe generalized and localized recessive dystrophic epidermolysis bullosa (RDEB) based on 
clinical signs, family history (negative) and immunofluorescent antigen mapping of skin biopsies. 
For genetic studies, genomic DNA was isolated from peripheral blood leukocytes. We used a next 
generation sequencing panel containing 508 genes including COL7A1 and other epidermolysis 
bullosa associated genes. The panel was developed to allow detection of the genetic background 
of early onset severe childhood recessive disorders. Sequence data were evaluated using Genetalk 
and HGMD database. Mutations obtained from next generation screening, were confirmed with 
Sanger sequencing. We found known homozygote COL7A1 (c.425A>G, p.K142R) mutations that 
are prevalent in central Europe in three patients (severe generalized RDEB), known homozygote 
c.6654C>G, G2218G synonym splice mutations in the same patients and two so far unknown 
mutations (c.5869C>T, p.R1957W; c.8457T>G, p.Y2819X) in the compound heterozygote adult 
patient (localized RDEB). On the other hand, no additional candidate mutations were found in 
epidermolysis bullosa associated genes (LAMB3, LAMC2) and genes (COL1A1, LAMA5) those 
protein products were described to interact with collagen VII and could potentially influence phe-
notypes of the disease.    
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Keratitis-Ichthyosis-Deafness Syndrome Associated Mutations Impair the Localization and 
Functions of Connexin 26
H Aypek and G Mese Izmir Institute of Technology, Izmir, Turkey
Connexins (Cx) form gap junctions and non-junctional hemichannels that play roles in several cellu-
lar mechanisms, including proliferation and differentiation. The importance of connexins for human 
physiology was shown by the association of mutations in several isoforms with various human hered-
itary disorders. Mutations in Cx26 cause both non-syndromic and syndromic deafness associated 
with skin disorders including keratitis-ichthyosis-deafness (KID) syndrome. In vitro characterization 
of Cx26 mutations suggested that mutations causing non-syndromic deafness and syndromic deaf-
ness show different properties, where the former ones result in loss-of-function and the latter ones 
cause gain-of-function mutations. For example, Cx26 mutations linked to keratitis-ichthyosis-deaf-
ness (KID) syndrome were shown to result in the formation of abnormal hemichannels. Here, we 
assessed the effect of two recently identified Cx26 mutations associated with KID syndrome, I30N 
and D50Y, on protein biosynthesis and channel function in both communication deficient cell lines 
and keratinocytes. Immunostaining experiments showed the failure of I30N and D50Y to form gap 
junction plaques at cell-cell contact sites, which is corroborated with an accumulation of mutant 
proteins in the Golgi apparatus. Fluorescent dye uptake assays revealed an increase in the uptake 
of neurobiotin and ethidium bromide into cells with I30N and D50Y mutations compared to WT 
containing cells, indicating the presence of abnormal hemichannels. Further, cells with mutant 
proteins appeared to have elevated intracellular calcium levels compared to WT transfected cells 
as measured by Fluo-3AM loading and flow cytometry analysis. In conclusion, I30N and D50Y 
mutations resulted in the formation of aberrant hemichannels similar to previously characterized 
KID syndrome mutations. They also caused an increase in intracellular calcium content, a process 
which may influence various cellular processes that may contribute to the development of epidermal 
phenotypes of KID syndrome.    
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Epidemiologic and genetic association between atopic dermatitis, rheumatoid arthritis, 
inflammatory bowel disease, and type-1 diabetes
H Baurecht,1 J Schmitt,2 E Rodriguez,1 W Lieb,6 C Gieger,3 A Irvine,4 N Novak5 and 
S Weidinger1 1 Department of Dermatology, Venereology and Allergy, University Hospital 
Schleswig-Holstein, Kiel, Germany, 2 Center for Evidence-based Healthcare, Medizinische 
Fakultät Carl Gustav Carus, TU Dresden, Dresden, Germany, 3 Institute of Genetic 
Epidemiology, Helmholtz Zentrum München, German Research Center for Environmental 
Health, Neuherberg, Germany, 4 Department of Paediatric Dermatology, Our Lady’s 
Children’s Hospital, Crumlin, Dublin, Ireland, 5 Department of Dermatology and Allergy, 
University of Bonn, Bonn, Germany and 6 Institute of Epidemiology and PopGen Biobank, 
University Hospital Schleswig-Holstein, Kiel, Germany
Atopic dermatitis (AD) is characterized by epidermal barrier failure and cutaneous inflammation. 
Molecular studies suggested shared genetic factors and immunological pathways with other inflam-
matory diseases as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD), but epidemiolog-
ical evidence is scarce. We test the hypothesis that prevalent AD is a risk factor for incident RA and 
IBD and inversely related to type-1 diabetes (T1D) and investigate RA, IBD, and T1D susceptibility 
loci in AD. This cohort study utilized data from German National Health Insurance beneficiaries 
age 40 or younger (n=655,815) from 2005 through 2011. Prevalent AD in 2005/2006 was defined 
as primary exposure, and incident RA, IBD, and T1D in 2007-2011 as primary outcomes. Risk 
ratios were calculated and established RA, IBD and T1D loci were explored in high density geno-
typing data. Patients with prevalent AD were at increased risk for incident RA (risk ratio (RR) 1.72, 
95%CI=1.25-2.37), CD (RR 1.34, 95%CI=1.11-1.61) and UC (RR 1.25, 95%CI=1.03-1.53). There 
was no disproportionate occurrence of known RA, CD, UC or T1D risk alleles in AD. AD is a risk 
factor for the development of RA and IBD. The excess comorbidity cannot be attributed to major 
known IBD and RA genetic risk factors.    
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Association of two rare genetic diseases confirmed by next generation sequencing
P Sillo,1 B Mayer,1 T Szemes,2 M Hýblova,2 D Pinter,1 M Mazan,1 K Nemeth1 and S Kárpáti1 1 
Semmelweis University, Budapest, Hungary and 2 Comenius University, Bratislava, Slovakia
Based on the characteristic skin symptoms and the positive family history for a blistering skin disease 
as well as on the immunofluorescent antigen mapping of the skin, generalized intermediate recessive 
dystrophic epidermolysis bullosa was diagnosed in a girl short after birth. Because of hyperactivity, 
attention disorder and learning disabilities she was also investigated for psychiatric and neurologic 
diseases. Niemann-Pick type C was first suspected when she also developed action dystonia, cere-
bellar ataxia, difficulty in swallowing, dysarthria and hepatosplenomegaly. Mutations of both rare 
genetic diseases were identified by next generation sequencing and a gene panel for early onset 
recessive disorders. She was compound heterozygote for COL7A1 c.5869C>T, p.R1957W and for 
c.7012C>T, p.R2338X mutations explaining her recessive dystrophic epidermolysis bullosa. In addi-
tion, she carried the compound heterozygous NPC1 c. 1185_1186insT, p. D396*, and c.2861C>T, 
p.S954L mutations as a genetic background for her Niemann-Pick type C disease symptoms.    
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Molecular analysis of antibiotic resistance and virulence features of Staphylococcus sp. strains 
isolated from patients with chronic leg ulcers
M Georgescu,1 I Gheorghe,3 CF GHIATAU,2 L DASCALU1 and CM Chifiriuc1 1 Microbiology 
Department, University of Bucharest, Faculty of Biology, Bucharest, Romania, 2 Dr. Carol 
Davila Central Military Universitary Emergency Hospital “SUUMC Dr. Carol Davila”, 
Bucharest, Romania and 3 Research Institute of the University of Bucharest - ICUB, 
Bucharest, Romania
Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common organisms isolated 
from clinical samples, being associated with high morbidity and mortality rates among hospital-
ized patients. The aim of this study was to evaluate the prevalence, antibiotic susceptibility and 
virulence profiles of methicillin-sensitive and methicillin-resistant Staphycolococcus sp. isolates 
collected from patients with chronic leg wounds. A total of 22 isolates of Staphylococcus spp. 
were collected from hospitalized patients with chronic leg wounds. The isolates were identified by 
using the conventional biochemical tests. We used PCR to determine the presence of the following 
genes responsible for antibiotic resistance and virulence profiles: mecA, SCC mec V1J, dcs, type 
IVa, ebps (elastin binding proteins), bbp (bone sialoprotein binding protein), hlg (haemolysin gamma 
gene). Of 22 isolates, 13 isolates (59%) were found to be MRSA. Regarding the genes responsible 
for antibiotic resistance, the PCR analysis revealed: 8 - mecA, 7 - SCC mec V1J, 2 – dcs, 6 - type 
IVa. The majority of Staphylococcus sp. isolates harbored the investigated virulence genes (hlg 
-12, ebps – 5, bbp – 2 strains). The majority of the Staphylococcus spp. isolates are both virulent 
and resistant to antibiotics, features which must be taken into account for a proper therapeutic 
management of chronic wound patients.    
